<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="splice">
            <roleset id="splice.01" name="" wordnet="3">
                <roles>
                    <role n="0" descr="gene or RNA&#x09;&#x09;&#x09;&#x09;&#x09;&#x09;&#x0A;" />
                    <role n="1" descr="specific component in gene/RNA to get spliced&#x09;&#x09;&#x09;// eg. extron, intron //&#x0A;" />
                    <role n="2" descr="gene product&#x09;&#x09;&#x09;&#x09;&#x09;&#x09;&#x09;// mRNA //&#x0A;" />
                    <role n="3" descr="location referring to organelle, cell or tissue&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>An additional observation with tandem splice 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation moving 5?-plus AG 6 nt down, so it is observed that RNA 3I alternately splashes only 20% as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>An additional observation with tandem substrates splice 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation moving 5?-plus AG 6 nt down, so that RNA 3I alternatively will only splash 20% efficiently as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>An additional observation with tandem substrates splice 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation moving 5?-plus AG 6 nt down, so that RNA 3I has the ability to section alternately only 20% as efficiently as 3F (Fig.1C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>An additional observation with tandem substrates splices 3? was that the efficiency of the ligation of the bimolecular exon 3 decreased step by step with each mutation moving the 5?-plus AG 6 nt down, so that RNA 3I only 20% was as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>An additional observation with tandem-repetition substrates 3 was that the efficiency of the bimolecular exon 3 ligation decreased progressively with each mutation that moved the 5?-gre plus AG 6 nt down, so that RNA 3I has the ability to splice only 20% efficiently as 3F RNA (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>An additional observation with the tandem splice 3? substrates was that the efficiency of the bimolecular exon ligation decreased step by step with each mutation that moved the 5?-plus AG 6 nt down, so that RNA 3I is able to divide only 20% as efficient as 3F (Fig.1 C Left).</text>
                    <arg n="2">RNA 3I</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>Consequently, exon 30 with the intron can be spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>El minigen casp-2 (C2) may have been efficiently spliced into in vitro, and the ratio of casp-2S to the produced casp-2L mRNA was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>El minigen casp-2 (C2) was observed to be efficiently spliced in vitro, and the ratio of casp-2S to the produced casp-2L mRNA was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>However, a pre-RNA containing mutations in SE2 is predominantly spliced with the 3 nt splice site 3605.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>However, a pre-mRNA containing mutations in SE2 will be spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>However, it has been shown that a pre-mRNA containing mutations in SE2 is spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>However, it is likely that a pre-mRNA containing mutations in SE2 will be spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>However, it is observed that a pre-mRNA containing mutations in SE2 is spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>It has been spliced that the Supt4h gene is usually cut from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>Pre-mRNAs of all these genes are shown to be spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Supt4h gene may have been spliced normally from five exons coded by chromosome 11.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>The minigene casp-2 (C2) has the ability to be efficiently spliced in vitro, and the ratio of casp-2S with the casp-2L mRNAs produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>The minigene casp-2 (C2) is able to be efficiently spliced in vitro, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>The mouse polymeric immunoglobulin receptor gene has exon 654 nt demonstrated to be efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>The mouse polymeric immunoglobulin receptor gene has exon 654 nt that is observed to be efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>The mouse polymeric immunoglobulin receptor gene has exon of 654 nt which is efficiently spliced into mRNA.</text>
                    <arg n="1">exon of 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>The mouses polymeric immunoglobulin receptor gene has a 654 nt exon that can be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>The mouses polymeric immunoglobulin receptor gene has a 654 nt exon that has been efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon 654 nt that has the ability to be efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 that has been efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>The mouses polymeric immunoglobulin receptor gene has exon 654 nt which has been efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>The pre-mRNAs of all these genes splashed with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>The pre-mRNAs of all these genes that have been pinned with few or no exon-spatched (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by the yeasts gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>The structure of different cDNA clones indicates that USF RNA has been shown to be differentially spliced, and the alternative use of exons can regulate functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>The structure of different cDNA clones indicates that USF RNA has been spliced differently, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>The structure of different cDNA clones indicates that USF RNA is observed as being spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>The structure of different cDNA clones indicates that USF RNA is spliced to be spalmate, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="33">
                    <text>The structure of different cDNA clones indicates that USF RNA will be spliced differently, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="34">
                    <text>The structure of different cDNA clones indicates that USF RNA will be spliced, and the alternative use of exons may regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>The structure of different cDNA clones spliced that USF RNA may have been blurred, and the alternative use of exons may regulate the functional USF protein levels.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>The structure of the different cDNA DNA clones indicates that USF RNA is spliced to be deployed, and the alternative use of the exon can regulate functional levels of USF proteins.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>The the casp-2 minigen (C2) can be efficiently spliced in vitro , and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>The the casp-2 minigen (C2) will be efficiently spliced in vitro , and the ratio of casp-2S to the produced casp-2L mRNA is similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>We also identify four transcriptive units that are able to be differentially spliced, but do not have an obvious open reading structure.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>We also spliced four transcriptional units that were different from each other, but do not contain any open obvious reading frame.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>We also spliced four transcriptional units that were found to be blurred, but did not contain an obvious open reading structure.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>We also spliced four transcriptional units with differential splicing, but without a clear open reading structure.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="43">
                    <text>We have also identified four transcriptional units which has been spliced to be spalmated but does not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="44">
                    <text>We have also spliced that four transcriptional units can be spalated but does not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate has the ability to be divided following via exon-skipping to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it has been shown that C2Gloi2 substrate is predominantly unfolded after exon escaping route at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="EGRAM" no="47">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, C2Gloi2 substrate is divided following exonon scaling route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="EGRAM" no="48">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, C2Gloi2 substrate is predominantly sectioned following exonon escaping route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 to line 1.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="EGRAM" no="49">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, C2Gloi2 substrate will be inclined after exon escaping route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="EGRAM" no="50">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, substrate C2Gloi2 can be spliced predominantly by following the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare line 3 with line 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, substrate C2Gloi2 is able to be spliced following the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, substrate C2Gloi2 is spliced predominantly following the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="53">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, substrate C2Gloi2 has been spliced following the exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>When incubated into nuclear extracts or spliced into HeLa cells, the A0 substrate (C2Gloi2) is found to be deployed after exon-skipping at a level similar to that obtained with the C2 substrate (undisplayed data and Fig. 2).</text>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="EGRAM" no="55">
                    <text>a caspasa-2 minigen construction can be made to be spliced into transcentric cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcentric cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="56">
                    <text>a caspasa-2 minigen construction may have been made to be alternatively spliced to transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="57">
                    <text>a minigen caspasa-2 construction can be done to be alternately spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="58">
                    <text>a minigen caspase-2 construction has been shown to be composed of A3 spliced (transfected cells and nuclear extracts).</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="EGRAM" no="59">
                    <text>a pre-RNA containing SE2 mutations, however, can be predominantly spliced with the splice 3 nt 3605 site.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="EGRAM" no="60">
                    <text>a pre-RNA containing mutations in SE2, however, is predominantly spliced using the splice nt 3605 3 site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="EGRAM" no="61">
                    <text>a pre-mRNA containing mutations in SE2 , however, is likely to be alternately spliced predominantly using the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="EGRAM" no="62">
                    <text>a pre-mRNA mutation containing EE2, however, EE2 is divided predominantly into A1 (spliced site of 3605 3.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="EGRAM" no="63">
                    <text>a pre-mRNA mutation containing EE2, however, was predominantly spliced into the site of 3, 505 and 3 splices.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="EGRAM" no="64">
                    <text>exons outside this range of size requires additional exotic and/or intron sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="65">
                    <text>exons outside this size range are spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="66">
                    <text>exons outside this size range has been shown to require additional exotic and/ or intrusive sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="67">
                    <text>exons outside this size range has been shown to require additional exotic and/ or intrusive sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="68">
                    <text>exons outside this size range is likely to require additional exotic and/or intrusive sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="69">
                    <text>exons outside this size range requires additional exotic and/or intronic sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="EGRAM" no="70">
                    <text>minigenous caspase-2 could be made to be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="71">
                    <text>minigenous caspase-2 is constituted and can be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="72">
                    <text>minigenous caspase-2 is observed to be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="EGRAM" no="73">
                    <text>pre-mRNAs of all these genes are observed splashed with little or no exon (ref.16; also Fig. 1 C and data not presented) spliced that correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="EGRAM" no="74">
                    <text>pre-mRNAs of all these genes can be spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="75">
                    <text>pre-mRNAs of all these genes that have been spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="EGRAM" no="76">
                    <text>pre-mRNAs of all these genes that may have been defocused with little or no exon-spatched (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="EGRAM" no="77">
                    <text>pre-mRNAs of all these genes that may have been spliced with few or no exon-spatched (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="EGRAM" no="78">
                    <text>pre-mRNAs of all these genes which have the ability to be spliced with little or no exon spacing (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="EGRAM" no="79">
                    <text>pre-mRNAs of all these genes will be cut with little or no exon-spatched (ref.16; also Fig. 1 C and data not spliced), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="EGRAM" no="80">
                    <text>the Supt4h gene can usually be spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="EGRAM" no="81">
                    <text>the Supt4h gene can usually be spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>A0 is observed to be made (a caspasa-2 minigen construction) that is spliced in transcent cells and nuclear extracts.</text>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>C2Gloi2 substrate are able to be spliced with exonon escaping pathway (ref. 16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>C2Gloi2 substrate are able to be spliced with exonon escaping route (ref. 16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>C2Gloi2 substrate are observed splashed with exonon escaping pathway (ref.16; also Fig. 1 C and data not presented) spliced that correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>C2Gloi2 substrate are observed splashed with exonon escaping route (ref.16; also Fig. 1 C and data not presented) spliced that correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>C2Gloi2 substrate are observed to be spliced with exonon escaping pathway (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>C2Gloi2 substrate are shown to be spliced with exon escaping route (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>C2Gloi2 substrate are shown to be spliced with exonon scaling route (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>C2Gloi2 substrate can be spliced with exonon escaping pathway (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>C2Gloi2 substrate can be spliced with exonon escaping route (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>C2Gloi2 substrate can be spliced with exonon scaling route (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>C2Gloi2 substrate can be spliced with via exon-skipping (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>C2Gloi2 substrate can normally be spliced from exon-skipping.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>C2Gloi2 substrate has also been spliced, which have been observed to be spalmated but contain no obvious open reading framework.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>C2Gloi2 substrate has the ability to be spliced with exon escaping route (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>C2Gloi2 substrate has the ability to be spliced with exonon escaping route (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>C2Gloi2 substrate have been shown to be spliced with via exon-skipping (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>C2Gloi2 substrate have the ability to be spliced with exonon escaping pathway (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>C2Gloi2 substrate is able to be normally spliced from exon escaping route.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>C2Gloi2 substrate is able to be spliced normally from exonon scaling route.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>C2Gloi2 substrate is observed as normally spliced from exon escaping route.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>C2Gloi2 substrate is observed as normally spliced from exonon escaping pathway.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>C2Gloi2 substrate is observed as normally spliced from via exon-skipping.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>C2Gloi2 substrate is observed to be deployed with exonon scaling route (ref.16; also Fig. 1 C and data not presented), spliced that correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>C2Gloi2 substrate is observed to be deployed with via exon-skipping (ref.16; also Fig. 1 C and data not presented), spliced that correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>C2Gloi2 substrate spread with exon escaping route (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>C2Gloi2 substrate spread with via exon-skipping (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>C2Gloi2 substrate that can be spliced with exon escaping route (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>C2Gloi2 substrate that can be spliced with exon-skipping (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>C2Gloi2 substrate that can be spliced with via exon-skipping (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>C2Gloi2 substrate that have been spliced with exon escaping route (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>C2Gloi2 substrate that have the ability to be spliced with via exon-skipping (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>C2Gloi2 substrate that may have been spliced with exon escaping route (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>C2Gloi2 substrate that may have been spliced with exon-skipping (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>C2Gloi2 substrate that will be spliced with exonon escaping route (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>C2Gloi2 substrate that will be spliced with exonon scaling route (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>C2Gloi2 substrate was generally spliced from exon-skipping.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>C2Gloi2 substrate was normally spliced from via exon-skipping.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>C2Gloi2 substrate was shown to be spliced with exon escaping route (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be treated by yeast genes expression machines.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>C2Gloi2 substrate was spliced with exon escaping route (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>C2Gloi2 substrate was spliced with exonon escaping pathway (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>C2Gloi2 substrate were observed to be spliced with exon escaping route (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>C2Gloi2 substrate were spliced with exon-skipping (ref.16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>C2Gloi2 substrate were spliced with exonon escaping route (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>C2Gloi2 substrate which have the ability to be spliced with exonon escaping pathway (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>C2Gloi2 substrate which were deployed with exonon escaping pathway (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>C2Gloi2 substrate which were deployed with exonon scaling route (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>C2Gloi2 substrate which were spliced with exonon escaping route (ref.16; also Fig. 1 C and data not presented) suggests that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>C2Gloi2 substrate which will be spliced with exonon escaping pathway (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>C2Gloi2 substrate will normally be spliced from exonon escaping pathway.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>C2Gloi2 substrate will usually be spliced from exon-skipping.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>C2Gloi2 substrate, however, has the ability to be alternately divided with exon escaping route spliced site.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>C2Gloi2 substrate, however, has the ability to be alternately divided with exonon scaling route spliced site.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>C2Gloi2 substrate, however, is likely to be predominantly spliced with exonon escaping route.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>Consequently, exon 30 with intron has spliced spleen.</text>
                    <arg n="1">exon 30 with intron</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>Consequently, exon 30 with intron has the ability to spliced spalated.</text>
                    <arg n="1">exon 30 with intron</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>Consequently, exon 30 with intron is spliced to be blurred.</text>
                    <arg n="1">exon 30 with intron</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>Consequently, exon 30 with the intron has been demonstrated to be spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>Consequently, exon 30 with the intron is able to be spliced.</text>
                    <arg n="1">exon 30 with the intron</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>Consequently, exon 30 with the intron, as suggested by our study has been shown to be spliced.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>Consequently, exon 30 with the intron, as suggested by our study is spliced to be blurred.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>Consequently, exon 30 with the intron, as suggested by our study, is spliced to be blurred.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study,</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>Consequently, exon 30 with the intron, as suggested in our study can spliced spalated.</text>
                    <arg n="1">exon 30 with the intron, as suggested in our study</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>Consequently, exon 30 with the intron, as suggested in our study has spliced spleen.</text>
                    <arg n="1">exon 30 with the intron, as suggested in our study</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>Consequently, exon 30 with the intron, as suggested in our study may spliced been spalated.</text>
                    <arg n="1">exon 30 with the intron, as suggested in our study</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>Consequently, exon 30 with the intron, as suggested in our study, can be spliced.</text>
                    <arg n="1">exon 30 with the intron, as suggested in our study,</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>Consequently, exon 30 with the intron, as suggested in our study, has the ability to spliced spalate.</text>
                    <arg n="1">exon 30 with the intron, as suggested in our study,</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>Consequently, exon 30 with the intron, as suggested in our study, will be spliced.</text>
                    <arg n="1">exon 30 with the intron, as suggested in our study,</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>Consequently, exon-skipping has been shown to be spliced.</text>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>Consequently, exon-skipping has spliced spalated.</text>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>Consequently, exon-skipping spliced spalted.</text>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>Consequently, it has been spliced that exon 30 with the intron, as suggested by our study is spalmate.</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>El minigen casp-2 (C2) can be done to be spliced into an alternative to in vitro.</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>El minigen casp-2 (C2) could be made to be spliced into in vitro.</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>El minigen casp-2 (C2) has been made to be spliced into in vitro.</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>El minigen casp-2 (C2) has been spliced to be used alternatively in in vitro.</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>El minigen casp-2 (C2) has the ability to be efficiently spliced in vitro, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>El minigen casp-2 (C2) has the ability to be efficiently spliced in vitro, and the ratio of casp-2S with the casp-2L mRNAs produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>El minigen casp-2 (C2) is able to be efficiently spliced in vitro, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>El minigen casp-2 (C2) is constituted and can be spliced into in vitro.</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>El minigen casp-2 (C2) may have been done to be spliced in an alternative with in vitro.</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>El minigen casp-2 (C2) was made and it was spliced into in vitro.</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>El minigen casp-2 (C2) will be made to be spliced into in vitro.</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>However, C2Gloi2 substrate is alternately spliced predominantly using exonon escaping pathway.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>However, C2Gloi2 substrate is alternately spliced predominantly using exonon escaping route.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>However, C2Gloi2 substrate is likely to be spliced more frequently with via exon-skipping slice site is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2 mutations).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>However, C2Gloi2 substrate was spliced predominantly by A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>However, C2Gloi2 substrate will predominantly be spliced into A1 (the site of slice nt 3605 3.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>However, Pre-RNAs of all these genes is alternately spliced predominantly using little or no exon-pulping.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>However, Pre-mRNAs of all these genes is likely to be spliced more frequently with few or no exon-spatch slice site is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2 mutations).</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>However, USF RNA will predominantly be spliced into A1 (the site of slice nt 3605 3.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>However, a minigen caspase-2 construction can be spliced predominantly by A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>However, a minigen caspase-2 construction can be spliced predominantly with A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>However, a minigen caspase-2 construction will be spliced predominantly into A1 (the site of section nt 3605 3.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>However, a mutation prior to mRNA containing EE2 was spliced predominantly by A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>However, a mutation prior to mRNA containing EE2 will predominantly be spliced into A1 (the site of slice nt 3605 3.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>However, a pre-RNA containing SE2 mutations can be spliced predominantly with A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>However, a pre-RNA containing SE2 mutations was spliced predominantly into A1 (the site of section nt 3605 3.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>However, a pre-RNA containing SE2 mutations will predominantly be spliced into A1 (the site of slice nt 3605 3.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>However, a pre-RNA containing mutations in SE2 can be spliced predominantly by A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>However, a pre-RNA containing mutations in SE2 is alternately spliced predominantly using nt splicetion site 3605 3.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt splicetion site 3605 3</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>However, a pre-RNA containing mutations in SE2 was spliced predominantly into A1 (the site of section nt 3605 3.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>However, a pre-RNA containing mutations in SE2 will be spliced predominantly by A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>However, four transcriptional units can be spliced predominantly with A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>However, four transcriptional units was spliced predominantly by A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>However, four transcriptive units was spliced predominantly by A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>However, it is likely that C2Gloi2 substrate is predominantly spliced with via exon-skipping slice 3 site.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>However, it is likely that C2Gloi2 substrate will divide more frequently with the spliced site exon-skipping is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>However, it is likely that a pre-RNA containing mutations in SE2 will divide more frequently with the spliced site nt splicetion site 3605 3 is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt splicetion site 3605 3</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>However, it is likely that gen Supt4h is predominantly spliced with five exons slice 3 site.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>However, it is likely that gen Supt4h will divide more frequently with the spliced site five exons is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2).</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>However, it is likely that pre-mRNAs of all these genes is predominantly spliced with little or no exon spatter slice 3 site.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>However, it is likely that pre-mRNAs of all these genes will divide more frequently with the spliced site few or no exon-spatched is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>However, it is likely that pre-mRNAs of all these genes will divide more frequently with the spliced site little or no exon spacing is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>However, it is likely that pre-mRNAs of all these genes will divide more frequently with the spliced site little or no exon-spatch is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>However, pre-mRNAs of all these genes is alternately spliced predominantly using little or no exon spacer.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacer</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>However, pre-mRNAs of all these genes is likely to be spliced more frequently with few or no spatter exon slice site is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2 mutations).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>However, pre-mRNAs of all these genes is likely to be spliced more frequently with little or no exon spatter slice site is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2 mutations).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>However, pre-mRNAs of all these genes is likely to be spliced more frequently with little or no exon-spatched slice site is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2 mutations).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>It has been shown that C2Gloi2 substrate can be spliced with exon-skipping (ref.16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>It has been shown that C2Gloi2 substrate can be spliced with exonon escaping pathway (ref.16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>It has been shown that a pre-RNA containing SE2 mutations can be spliced with nt 3605 (ref.16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>It has been shown that a pre-RNA containing mutations in SE2 can be spliced with a 3605 3 coupling site (ref.16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>It has been shown that a pre-RNA containing mutations in SE2 can be spliced with the 3 nt 3605 (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>It has been shown that pre-mRNAs of all these genes can be spliced with few or no spatter exon (ref.16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>It has been shown that pre-mRNAs of all these genes can be spliced with little or no exon-spatch (ref.16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>It has been shown that pre-mRNAs of all these genes can be spliced with little or no exon-spatched (ref.16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>It has been shown that substrate C2Gloi2 can be spliced with exon escapement pathway (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>It has been shown that the Supt4h gene can be spliced with five exons coded by chromosome 11 (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>It has been spliced that The minigene casp-2 (C2) is used alternatively in in vitro.</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>It has been spliced that a caspasa-2 minigen construction is used alternatively in transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>It has been spliced that a minigen caspasa-2 building is used alternatively in transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>It has been spliced that a minigen caspase-2 construction is used alternatively in transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>It is observed that a 654 nt exon requires additional exonic and/or intron sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>It is observed that an exon nt 654 requires additional exonic and/or intron sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>It is observed that an exon nt 654 requires additional exotic and/or intronic sequences to be spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>It is observed that an exon of 654 nt requires additional exonic and/or intronic sequences to be spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>It is observed that an exon of 654 nt requires additional exotic and/or intronic sequences to be spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>It is observed that exon of 654 nt requires additional exonic and/or intron sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">exon of 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>It is observed that exon of 654 nt requires additional exotic and/or intronic sequences to be spliced into mRNA.</text>
                    <arg n="1">exon of 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>It is observed that exons outside this range of size requires additional exonic and/or intron sequences to be effectively spliced into mature RNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>It is observed that exons outside this size range requires additional exonic and/or intronic sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>It is observed that the construction of a caspasa-2 minigen is made from a minigen caspasa-2 building, which is alternately spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>It is observed that the construction of a caspasa-2 minigen is made from a minigen caspasa-2 building, which is alternately spliced into transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>It is observed that the construction of a caspasa-2 minigen is made from a minigen caspase-2 building, which is alternately spliced into transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>It is observed that the construction of a caspasa-2 minigen is made from the casp-2 minigen (C2), which is alternately spliced into in vitro.</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>Pre-RNAs of all these genes can be spliced with little or no exon-pulping (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>Pre-RNAs of all these genes can normally be spliced from little or no exon-pulping.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>Pre-RNAs of all these genes can usually be divided from the little or no exon-pulping spliced by chromosome 11.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>Pre-RNAs of all these genes have been shown to be spliced with little or no exon-pulping (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>Pre-RNAs of all these genes is observed to be deployed with little or no exon-pulping (ref.16; also Fig. 1 C and data not presented), spliced that correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>Pre-RNAs of all these genes may have been spliced with little or no exon-pulping (ref.16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>Pre-RNAs of all these genes that can be spliced with little or no exon-pulping (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>Pre-RNAs of all these genes that may have been defocused with little or no exon-pulping (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>Pre-RNAs of all these genes was shown to be spliced with little or no exon-pulping (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be treated by yeast genes expression machines.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>Pre-RNAs of all these genes, however, has the ability to be alternately divided with little or no exon-pulping spliced site.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>Pre-RNAs of all these genes, however, is likely to be predominantly spliced with little or no exon-pulping.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>Pre-RNAs of all these genes, however, may have been alternately spliced predominantly with little or no exon-pulping slice 3 site.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>Pre-mRNA of all these genes can be spliced with small or no exon escapement (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>Pre-mRNA of all these genes has been spliced to be generally cut from small or no exon escapement.</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>Pre-mRNA of all these genes is able to normally be spliced from small or no exon escapement.</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>Pre-mRNA of all these genes is observed to be deployed with small or no exon escapement (ref.16; also Fig. 1 C and data not presented), spliced that correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>Pre-mRNA of all these genes is shown to be spliced with small or no exon escapement (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>Pre-mRNA of all these genes spread with small or no exon escapement (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>Pre-mRNA of all these genes was normally spliced from small or no exon escapement.</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>Pre-mRNA of all these genes were spliced with small or no exon escapement (ref.16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>Pre-mRNA of all these genes which will be spliced with small or no exon escapement (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>Pre-mRNAs of all these genes are observed splashed with few or no exon-spatch (ref.16; also Fig. 1 C and data not presented) spliced that correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>Pre-mRNAs of all these genes are observed to be spliced with little or no exon-skipping (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>Pre-mRNAs of all these genes is able to be normally spliced from little or no exon-skipping.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>Pre-mRNAs of all these genes is observed as normally spliced from few or no exon-spatch.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>Pre-mRNAs of all these genes is observed to be deployed with few or no exon-spatch (ref.16; also Fig. 1 C and data not presented), spliced that correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>Pre-mRNAs of all these genes may have been normally spliced from little or no exon-skipping.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>Pre-mRNAs of all these genes was generally spliced from little or no exon-skipping.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>Pre-mRNAs of all these genes was normally spliced from few or no exon-spatch.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>Pre-mRNAs of all these genes was spliced with few or no exon-spatch (ref. 16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by yeast genes expression machines.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>Pre-mRNAs of all these genes was spliced with little or no exon-skipping (ref. 16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by yeast genes expression machines.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>Pre-mRNAs of all these genes will usually be spliced from little or no exon-skipping.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>Pre-mRNAs of all these genes, however, has the ability to be alternately divided with few or no exon-spatch spliced site.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>Pre-mRNAs of all these genes, however, was predominantly divided with little or no exon-skipping spliced site.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>Supt4h gene can usually be divided from the five exons coded by chromosome 11 spliced by chromosome 11.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>Supt4h gene that were spliced with five exons coded by chromosome 11 (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>Supt4h gene that will be spliced with five exons coded by chromosome 11 (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>Supt4h gene were observed to be spliced with five exons coded by chromosome 11 (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>Supt4h gene which have the ability to be spliced with five exons coded by chromosome 11 (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>Supt4h gene which will be spliced with five exons coded by chromosome 11 (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>Supt4h gene, however, is likely to be predominantly spliced with five exons coded by chromosome 11.</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>The C2Gloi2 substrate splashed with exon escaping route (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>The C2Gloi2 substrate splashed with exonon scaling route (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by yeast gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>The C2Gloi2 substrate spliced to be deployed with exon escaping route (ref. 16; also Fig. 1 C and data not presented) suggests that the correct inclusion of the exon can be controlled by the yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>The C2Gloi2 substrate spliced to be deployed with exonon scaling route (ref. 16; also Fig. 1 C and data not presented) suggests that the correct inclusion of the exon can be controlled by the yeast gene expression machine.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>The C2Gloi2 substrate that have been pinned with exonon scaling route (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by the yeasts gene expression machinery.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>The El minigen casp-2 (C2) is efficiently spliced in vitro, and the relationship between the CASp-2 and casp-2L mRNAs produced was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">El minigen casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>The Pre-RNAs of all these genes that have been pinned with little or no exon-pulping (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by the yeasts gene expression machinery.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>The Pre-mRNA of all these genes will be spliced with small or no exon escapement (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>The Pre-mRNAs of all these genes may have been spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>The The minigene casp-2 (C2) will be efficiently spliced in vitro , and the relationship between the CASp-2 and CASp-2L mRNAs produced is similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>The a caspasa-2 can be efficiently spliced transcent cells and nuclear extracts , and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a caspasa-2</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>The a caspasa-2 minigen construction has been efficiently spliced transcent cells and nuclear extracts, and the relationship between the CASp-2 and casp-2L mRNAs produced was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>The a caspasa-2 minigen construction is efficiently spliced transcentric cells and nuclear extracts, and the relationship between the CASp-2 and casp-2L mRNAs produced was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcentric cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>The a caspasa-2 minigen construction may have been efficiently spliced transcent cells and nuclear extracts, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>The a caspasa-2 minigen construction will be efficiently spliced transcent cells and nuclear extracts , and the ratio of casp-2S to the produced casp-2L mRNA is similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>The a caspasa-2 minigen construction will be efficiently spliced transcent cells and nuclear extracts , and the relationship between the CASp-2 and CASp-2L mRNAs produced is similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>The a minigen caspasa-2 building has been efficiently spliced transient cells and nuclear extracts , and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>The a minigen caspasa-2 building is efficiently spliced transfected cells and nuclear extracts, and the relationship between the CASp-2 and casp-2L mRNAs produced was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>The a minigen caspasa-2 construction will be efficiently spliced transfected cells and nuclear extracts , and the relationship between the CASp-2 and CASp-2L mRNAs produced is similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>The a minigen caspase-2 building has been efficiently spliced transient cells and nuclear extracts , and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a minigen caspase-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>The a minigen caspase-2 construction has been efficiently spliced transfected cells and nuclear extracts, and the relationship between the CASp-2 and casp-2L mRNAs produced was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>The a pre-RNA containing SE2 mutations spliced to be deployed with nt 3605 (ref. 16; also Fig. 1 C and data not presented) suggests that the correct inclusion of the exon can be controlled by the yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>The a pre-RNA containing SE2 mutations will be spliced with nt 3605 slice 3 site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>The a pre-RNA containing mutations in SE2 spliced to be deployed with a 3605 3 coupling site (ref. 16; also Fig. 1 C and data not presented) suggests that the correct inclusion of the exon can be controlled by the yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>The a pre-RNA containing mutations in SE2 that have been pinned with a 3605 3 coupling site (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by the yeasts gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>The a pre-RNA containing mutations in SE2 will be spliced with a 3605 3 coupling site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>The a pre-mRNA mutation containing EE2 that have been pinned with nt 3605 (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by the yeasts gene expression machinery.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>The gen Supt4h splashed with five exons (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by yeast gene expression machinery.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>The gen Supt4h will be spliced with five exons (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>The minigene casp-2 (C2) could be made to alternately spliced into in vitro.</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>The minigene casp-2 (C2) is made to be alternatively spliced into in vitro.</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>The minigene casp-2 (C2) may have been done to be spliced in an alternative with in vitro.</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>The minigene casp-2 (C2) may have been made to be alternatively spliced to in vitro.</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>The minigene casp-2 (C2) may have been shown to be efficiently spliced in vitro , and the relationship between the produced casp-2 and casp-2L mRNAs is similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">The minigene casp-2 (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>The minigenous caspase-2 has been efficiently spliced transfected cells and nuclear extracts , and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>The mouse polymer immunoglobulin receptor gene has the ability to be efficiently spliced into exon 654 nt which has the ability to be penetrated into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is able to be efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon 654 nt demonstrated to be efficiently spliced into mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon 654 nt that has been efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon 654 nt that has been observed to be efficiently spliced into mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon 654 nt that is observed to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon nt 654 being able to be efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon nt 654 that has been observed to be efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon nt 654 that has been spliced to be efficient for its application in mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon of 654 nt being able to be spliced efficiently into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon of 654 nt that can be efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon of 654 nt that has been spliced to be efficient for its application in the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon of 654 nt that will be efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>The mouse polymeric immunoglobulin receptor gene has an exon of 654 nt which is efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>The mouse polymeric immunoglobulin receptor gene has exon of 654 nt being able to be efficiently spliced into mRNA.</text>
                    <arg n="1">exon of 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this range of size being able to be efficiently spliced into mature RNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this range of size being able to be efficiently spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this range of size that can be efficiently spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this range of size that is able to be efficiently spliced into mature RNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this range of size that is observed to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this range of size that will be efficiently spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this size range being able to be efficiently spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this size range being able to be spliced efficiently into mature RNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this size range demonstrated to be efficiently spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this size range that has been efficiently spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this size range that will be efficiently spliced into mature RNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>The mouse polymeric immunoglobulin receptor gene has exons outside this size range which is efficiently spliced into mature RNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>The mouses polymeric immunoglobulin receptor gene has a 654 nt exon efficiently spliced in the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>The mouses polymeric immunoglobulin receptor gene has a 654 nt exon having been efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>The mouses polymeric immunoglobulin receptor gene has a 654 nt exon that is efficiently spliced in the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>The mouses polymeric immunoglobulin receptor gene has a 654 nt exon which may have been efficiently spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon 654 nt that is capable of being efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 having been efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="257">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 observed to be effectively spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="258">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 that has been efficiently spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="259">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 that has the ability to be efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="260">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 that is efficiently spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="261">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 that was efficiently spliced to the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="262">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 which can be efficiently spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="263">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 which is observed to be effectively spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="264">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon nt 654 which is observed to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="265">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon of 654 nt efficiently spliced in the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="266">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon of 654 nt that has the ability to be efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="267">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon of 654 nt that may spliced been efficiently spalated in the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="268">
                    <text>The mouses polymeric immunoglobulin receptor gene has an exon of 654 nt which has the ability to be efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="269">
                    <text>The mouses polymeric immunoglobulin receptor gene has exon 654 nt that has been efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="270">
                    <text>The mouses polymeric immunoglobulin receptor gene has exon 654 nt that was efficiently spliced to mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="271">
                    <text>The mouses polymeric immunoglobulin receptor gene has exon 654 nt that will be efficiently spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="272">
                    <text>The mouses polymeric immunoglobulin receptor gene has exon of 654 nt having been efficiently spliced into mRNA.</text>
                    <arg n="1">exon of 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="273">
                    <text>The mouses polymeric immunoglobulin receptor gene has exon of 654 nt that was efficiently spliced to mRNA.</text>
                    <arg n="1">exon of 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="274">
                    <text>The mouses polymeric immunoglobulin receptor gene has exon of 654 nt which has been efficiently spliced into mRNA.</text>
                    <arg n="1">exon of 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="275">
                    <text>The mouses polymeric immunoglobulin receptor gene has exons outside this range of size that can be efficiently spliced into mature RNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="276">
                    <text>The mouses polymeric immunoglobulin receptor gene has exons outside this range of size which is observed to be efficiently spliced into mature RNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="277">
                    <text>The mouses polymeric immunoglobulin receptor gene has exons outside this range of size which will be efficiently spliced into mature RNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="278">
                    <text>The mouses polymeric immunoglobulin receptor gene has exons outside this size range efficiently spliced in mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="279">
                    <text>The mouses polymeric immunoglobulin receptor gene has exons outside this size range that is efficiently spliced into mature RNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="280">
                    <text>The mouses polymeric immunoglobulin receptor gene has exons outside this size range that may spliced been efficiently spalated in mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="281">
                    <text>The mouses polymeric immunoglobulin receptor gene has exons outside this size range which has the ability to be efficiently spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="282">
                    <text>The mouses polymeric immunoglobulin receptor gene has exons outside this size range which is observed to be efficiently spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="283">
                    <text>The mouses polymeric immunoglobulin receptor gene spliced an exon 654 nt efficiently spalated in the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="284">
                    <text>The polymeric immunoglobulin receptor gene in mice has an exon 654 nt that has been efficiently spliced into mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="285">
                    <text>The polymeric immunoglobulin receptor gene in mice has an exon 654 nt that has been efficiently spliced into the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="286">
                    <text>The pre-mRNAs of all these genes splashed with few or no exon-spatched (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="287">
                    <text>The pre-mRNAs of all these genes splashed with little or no exon spacer (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacer</arg>
                </example>
                <example src="PERMUTATE" no="288">
                    <text>The pre-mRNAs of all these genes splashed with little or no exon spacing (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="289">
                    <text>The pre-mRNAs of all these genes spliced to be deployed with little or no exon spacer (ref. 16; also Fig. 1 C and data not presented) suggests that the correct inclusion of the exon can be controlled by the yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacer</arg>
                </example>
                <example src="PERMUTATE" no="290">
                    <text>The pre-mRNAs of all these genes will be spliced with few or no exon-spatch (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="291">
                    <text>The structure of different cDNA clones indicates that C2Gloi2 substrate has been shown to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="292">
                    <text>The structure of different cDNA clones indicates that C2Gloi2 substrate is observed to be differentially spliced, and the alternative use of exons can regulate functional USF protein levels.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="293">
                    <text>The structure of different cDNA clones indicates that C2Gloi2 substrate will be spliced, and the alternative use of exons may regulate the functional USF protein levels.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="294">
                    <text>The structure of different cDNA clones indicates that a minigen caspase-2 construction can be spliced differently, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="295">
                    <text>The structure of different cDNA clones indicates that a minigen caspase-2 construction can be spliced, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="296">
                    <text>The structure of different cDNA clones indicates that a minigen caspase-2 construction has the ability to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="297">
                    <text>The structure of different cDNA clones indicates that a mutation prior to mRNA containing EE2 has been demonstrated to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="298">
                    <text>The structure of different cDNA clones indicates that a mutation prior to mRNA containing EE2 is observed as being spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="299">
                    <text>The structure of different cDNA clones indicates that a mutation prior to mRNA containing EE2 may have been spliced, and the alternative use of exon may regulate the functional USF protein levels.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="300">
                    <text>The structure of different cDNA clones indicates that a mutation prior to mRNA containing EE2 was differentially spliced, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="301">
                    <text>The structure of different cDNA clones indicates that a pre-RNA containing SE2 mutations has been spliced differently, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="302">
                    <text>The structure of different cDNA clones indicates that a pre-RNA containing SE2 mutations has the ability to be spliced, and the alternative use of exons can regulate the functional levels of USF protein.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="303">
                    <text>The structure of different cDNA clones indicates that a pre-RNA containing SE2 mutations is observed to be differentially spliced, and the alternative use of exons can regulate functional USF protein levels.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="304">
                    <text>The structure of different cDNA clones indicates that a pre-RNA containing SE2 mutations may have been spliced, and the alternative use of exons may regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="305">
                    <text>The structure of different cDNA clones indicates that a pre-RNA containing SE2 mutations was differentially spliced, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="306">
                    <text>The structure of different cDNA clones indicates that a pre-RNA containing mutations in SE2 has the ability to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="307">
                    <text>The structure of different cDNA clones indicates that a pre-RNA containing mutations in SE2 is able to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="308">
                    <text>The structure of different cDNA clones indicates that a pre-RNA containing mutations in SE2 is observed as being spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="309">
                    <text>The structure of different cDNA clones indicates that a pre-RNA containing mutations in SE2 is spliced to be spalmate, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="310">
                    <text>The structure of different cDNA clones indicates that a pre-mRNA mutation containing EE2 has the ability to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="311">
                    <text>The structure of different cDNA clones indicates that four transcriptional units can be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="PERMUTATE" no="312">
                    <text>The structure of different cDNA clones indicates that four transcriptional units has been demonstrated to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="PERMUTATE" no="313">
                    <text>The structure of different cDNA clones indicates that four transcriptional units has the ability to be spliced, and the alternative use of exons can regulate the functional levels of USF protein.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="PERMUTATE" no="314">
                    <text>The structure of different cDNA clones indicates that four transcriptional units is observed to be differentially spliced, and the alternative use of exons can regulate functional USF protein levels.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="PERMUTATE" no="315">
                    <text>The structure of different cDNA clones indicates that four transcriptional units was differentially spliced, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="PERMUTATE" no="316">
                    <text>The structure of different cDNA clones indicates that four transcriptive units can be spliced differently, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="PERMUTATE" no="317">
                    <text>The structure of different cDNA clones indicates that four transcriptive units is observed as being spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="PERMUTATE" no="318">
                    <text>The structure of different cDNA clones spliced that C2Gloi2 substrate has been pulsed, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="319">
                    <text>The structure of different cDNA clones spliced that C2Gloi2 substrate is able to spray, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="320">
                    <text>The structure of different cDNA clones spliced that a minigen caspase-2 construction has been pulsed, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="321">
                    <text>The structure of different cDNA clones spliced that a minigen caspase-2 construction is able to spray, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="322">
                    <text>The structure of different cDNA clones spliced that a mutation prior to mRNA containing EE2 has the ability to be palatined, and the alternative use of exons can regulate the protein levels of functional USF.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="323">
                    <text>The structure of different cDNA clones spliced that a mutation prior to mRNA containing EE2 may have been blurred, and the alternative use of exons may regulate the functional USF protein levels.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="324">
                    <text>The structure of different cDNA clones spliced that a pre-RNA containing SE2 mutations has been blurred, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="325">
                    <text>The structure of different cDNA clones spliced that a pre-RNA containing SE2 mutations has been pulsed, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="326">
                    <text>The structure of different cDNA clones spliced that a pre-RNA containing mutations in SE2 has been blurred, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="327">
                    <text>The structure of different cDNA clones spliced that a pre-mRNA mutation containing EE2 has been blurred, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="328">
                    <text>The structure of different cDNA clones spliced that a pre-mRNA mutation containing EE2 will be blurred, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="329">
                    <text>The structure of different cDNA clones spliced that four transcriptional units has been pulsed, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">four transcriptional units</arg>
                </example>
                <example src="PERMUTATE" no="330">
                    <text>The structure of different cDNA clones spliced that four transcriptive units will be blurred, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="PERMUTATE" no="331">
                    <text>The structure of the different cDNA DNA clones indicates that C2Gloi2 substrate is spliced to be deployed, and the alternative use of the exon can regulate functional levels of USF proteins.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="332">
                    <text>The structure of the different cDNA DNA clones indicates that a pre-RNA containing SE2 mutations is spliced to be deployed, and the alternative use of the exon can regulate functional levels of USF proteins.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="333">
                    <text>The structure of the different cDNA DNA clones indicates that a pre-RNA containing mutations in SE2 has been spliced, and alternative use of the exon may regulate functional levels of USF proteins.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="334">
                    <text>The structure of the different cDNA DNA clones indicates that a pre-RNA containing mutations in SE2 is spliced to be deployed, and the alternative use of the exon can regulate functional levels of USF proteins.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="335">
                    <text>The substrate C2Gloi2 may have been spliced with the exon escapement pathway (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="336">
                    <text>The the Supt4h gene spliced to be deployed with five exons coded by chromosome 11 (ref. 16; also Fig. 1 C and data not presented) suggests that the correct inclusion of the exon can be controlled by the yeast gene expression machine.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="337">
                    <text>We also identified C2Gloi2 substrate that may have been spliced differently, but that do not contain any obvious open reading frame.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="338">
                    <text>We also identified USF RNA that are observed as being of spliced tissue, but do not contain any obvious open reading frame.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="PERMUTATE" no="339">
                    <text>We also identified USF RNA that were spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="PERMUTATE" no="340">
                    <text>We also identified a minigen caspase-2 construction that are observed as being of spliced tissue, but do not contain any obvious open reading frame.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="341">
                    <text>We also identified a minigen caspase-2 construction that could have been differentially spliced but did not contain any obvious open reading framework.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="342">
                    <text>We also identified a minigen caspase-2 construction that were differentially spliced but did not contain any obvious open reading framework.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="343">
                    <text>We also identified a mutation prior to mRNA containing EE2 that were differentially spliced but did not contain any obvious open reading framework.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="344">
                    <text>We also identified a mutation prior to mRNA containing EE2 that were differentially spliced, but did not contain any obvious open reading frame.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="345">
                    <text>We also identified a mutation prior to mRNA containing EE2 that were observed as being differentially spliced, but do not contain an open reading table.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="346">
                    <text>We also identified a mutation prior to mRNA containing EE2 that were spliced differently, but do not contain any obvious open reading frame.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="347">
                    <text>We also identified a mutation prior to mRNA containing EE2 that were spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="348">
                    <text>We also identified a pre-RNA containing SE2 mutations that could have been differentially spliced, but did not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="349">
                    <text>We also identified a pre-RNA containing mutations in SE2 that could have been differentially spliced, but did not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="350">
                    <text>We also identified a pre-mRNA mutation containing EE2 that may have been spliced differently, but that do not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="351">
                    <text>We also identified a pre-mRNA mutation containing EE2 that were differentially spliced, but did not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="352">
                    <text>We also identified four transcriptive units that could have been differentially spliced, but did not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="PERMUTATE" no="353">
                    <text>We also identified four transcriptive units that were differentially spliced but did not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="PERMUTATE" no="354">
                    <text>We also identify C2Gloi2 substrate being able to be spliced, but without a clear open reading structure.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="355">
                    <text>We also identify C2Gloi2 substrate that can be differentially spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="356">
                    <text>We also identify USF RNA that can be differentially spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="PERMUTATE" no="357">
                    <text>We also identify USF RNA that can be spliced differently, but do not contain any obvious open reading frame.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="PERMUTATE" no="358">
                    <text>We also identify a minigen caspase-2 construction that are able to be differentially spliced, but do not have an obvious open reading structure.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="359">
                    <text>We also identify a minigen caspase-2 construction that will be spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="360">
                    <text>We also identify a pre-RNA containing SE2 mutations being able to be spliced, but without a clear open reading structure.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="361">
                    <text>We also identify a pre-RNA containing SE2 mutations that are spliced as being unfolded, but they do not have an open reading table.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="362">
                    <text>We also identify a pre-RNA containing SE2 mutations that will be spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="363">
                    <text>We also identify a pre-RNA containing mutations in SE2 that can be spliced, but do not contain an obvious open reading structure.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="364">
                    <text>We also identify a pre-RNA containing mutations in SE2 that may have been spread, but does not spliced any obvious open reading frame.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="365">
                    <text>We also identify a pre-mRNA mutation containing EE2 being able to be spliced, but without a clear open reading structure.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="366">
                    <text>We also identify a pre-mRNA mutation containing EE2 that can be spliced differently, but do not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="367">
                    <text>We also identify four transcriptive units that can be spliced differently, but do not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="PERMUTATE" no="368">
                    <text>We also identify four transcriptive units that can be spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="PERMUTATE" no="369">
                    <text>We also identify four transcriptive units that will be spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="PERMUTATE" no="370">
                    <text>We also spliced C2Gloi2 substrate that proved to be differentially from each other, but does not contain any obvious open reading frame.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="371">
                    <text>We also spliced C2Gloi2 substrate that were found to be blurred, but did not contain an obvious open reading structure.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="372">
                    <text>We also spliced C2Gloi2 substrate that were found to be blurred, but without a clear open reading structure.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="373">
                    <text>We also spliced C2Gloi2 substrate that were spalmated but did not contain any obvious open reading framework.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="374">
                    <text>We also spliced a minigen caspase-2 construction that were different from each other, but do not contain any open obvious reading frame.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="375">
                    <text>We also spliced a pre-RNA containing mutations in SE2 that could have been spread, but did not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="376">
                    <text>We also spliced a pre-RNA containing mutations in SE2 that were found to be blurred, but did not contain an obvious open reading structure.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="377">
                    <text>We have also identified C2Gloi2 substrate that may have been differentially spliced, but that do not contain any obvious open reading framework.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="378">
                    <text>We have also identified C2Gloi2 substrate that will be differentially spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="379">
                    <text>We have also identified USF RNA spliced but without an obvious open reading framework.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="PERMUTATE" no="380">
                    <text>We have also identified a minigen caspase-2 construction that can be differentially spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="381">
                    <text>We have also identified a minigen caspase-2 construction that has been spliced to be differentially interwoven but does not contain any obvious open reading framework.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="382">
                    <text>We have also identified a minigen caspase-2 construction that have been spliced to be differentially interwoven but do not contain any obvious open reading framework.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="383">
                    <text>We have also identified a mutation prior to mRNA containing EE2 that will be differentially spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">a mutation prior to mRNA containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="384">
                    <text>We have also identified a pre-RNA containing SE2 mutations that will be differentially spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="PERMUTATE" no="385">
                    <text>We have also identified a pre-RNA containing mutations in SE2 that have been observed to be differentially spliced but contain no obvious open reading framework.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="386">
                    <text>We have also identified a pre-RNA containing mutations in SE2 that have been spliced to be differentially interwoven but do not contain any obvious open reading framework.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="387">
                    <text>We have also identified a pre-RNA containing mutations in SE2 which has been spliced to be spalmated but does not contain any obvious open reading framework.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="388">
                    <text>We have also identified a pre-mRNA mutation containing EE2 that can be differentially spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="389">
                    <text>We have also identified a pre-mRNA mutation containing EE2 that have been observed to be differentially spliced but contain no obvious open reading framework.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="390">
                    <text>We have also identified four transcriptive units that can be spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="PERMUTATE" no="391">
                    <text>We have also identified four transcriptive units that have been spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="PERMUTATE" no="392">
                    <text>We have also identified four transcriptive units that will be differentially spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="PERMUTATE" no="393">
                    <text>We have also spliced C2Gloi2 substrate that may have been spalted but does not contain any obvious open reading framework.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="394">
                    <text>We have also spliced USF RNA that may have been spalted but does not contain any obvious open reading framework.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="PERMUTATE" no="395">
                    <text>We have also spliced a minigen caspase-2 construction that will be cut but do not contain any obvious open reading framework.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="396">
                    <text>We have also spliced four transcriptive units that may have been spalted but does not contain any obvious open reading framework.</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="PERMUTATE" no="397">
                    <text>We have also spliced that C2Gloi2 substrate can be spalated but does not contain any obvious open reading framework.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                </example>
                <example src="PERMUTATE" no="398">
                    <text>We have also spliced that USF RNA can be spalated but does not contain any obvious open reading framework.</text>
                    <arg n="0">USF RNA</arg>
                </example>
                <example src="PERMUTATE" no="399">
                    <text>We have also spliced that a minigen caspase-2 construction can be spalated but does not contain any obvious open reading framework.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="400">
                    <text>We have also spliced that a pre-mRNA mutation containing EE2 can be spalated but does not contain any obvious open reading framework.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="401">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate can be divided predominantly by following exon escaping route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="402">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate can be inclined following exon-skipping to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="403">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate can be inclined following exonon escaping pathway to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="404">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate has the ability to be divided following exon-skipping to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="405">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate may have been deployed predominantly following exon escaping route to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="406">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate may have been imputed following exon escaping route to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="407">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate will be deployed predominantly following exon escaping route to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="408">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate will be deployed predominantly following exonon escaping route to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="409">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, C2Gloi2 substrate will be deployed predominantly following exonon scaling route to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="410">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, Pre-mRNA of all these genes can be divided predominantly by following small or no exon escapement to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2).</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="411">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, Pre-mRNA of all these genes will be deployed predominantly following small or no exon escapement to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="412">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, Supt4h gene can be inclined following five exons coded by chromosome 11 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="413">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, Supt4h gene has the ability to be divided following five exons coded by chromosome 11 to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="414">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, Supt4h gene will be deployed predominantly following five exons coded by chromosome 11 to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="415">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing SE2 mutations can be divided predominantly by following nt 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="416">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing SE2 mutations has the ability to be divided following nt 3605 to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="417">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing SE2 mutations is able to be deployed following nt 3605 slice 3 site to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="PERMUTATE" no="418">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing SE2 mutations may have been deployed predominantly following nt 3605 slice 3 site to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="PERMUTATE" no="419">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing SE2 mutations will be deployed predominantly following nt 3605 to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="420">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing mutations in SE2 is able to be deployed following nt splicetion site 3605 3 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt splicetion site 3605 3</arg>
                </example>
                <example src="PERMUTATE" no="421">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing mutations in SE2 may have been deployed predominantly following the 3 nt 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="422">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing mutations in SE2 will be deployed predominantly following a 3605 3 coupling site to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="423">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-mRNA mutation containing EE2 can be divided predominantly following the A1 level (exonon scaling route) to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                </example>
                <example src="PERMUTATE" no="424">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-mRNA mutation containing EE2 may have been imputed following nt 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="425">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it has been shown that C2Gloi2 substrate is predominantly unfolded after exonon escaping pathway at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="426">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it has been shown that C2Gloi2 substrate is predominantly unfolded after exonon escaping route at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="427">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it has been shown that C2Gloi2 substrate is predominantly unfolded after exonon scaling route at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="428">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it has been shown that Pre-mRNAs of all these genes is predominantly unfolded after few or no exon-spatch at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="429">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it has been shown that a pre-RNA containing SE2 mutations is predominantly unfolded after nt 3605 slice 3 site at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="PERMUTATE" no="430">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it has been shown that pre-mRNAs of all these genes is predominantly unfolded after little or no exon at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="431">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it has been shown that pre-mRNAs of all these genes is predominantly unfolded after little or no exon-spatch at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="432">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it has been shown that substrate C2Gloi2 is predominantly unfolded after exon escapement pathway at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="433">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that C2Gloi2 substrate is deployed following exonon escaping pathway to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="434">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that C2Gloi2 substrate is deployed following exonon scaling route to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="435">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that Pre-mRNA of all these genes is deployed following small or no exon escapement to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="436">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that Supt4h gene is predominantly deployed following five exons coded by chromosome 11 to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="437">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that a pre-RNA containing mutations in SE2 is deployed following a 3605 3 coupling site to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="438">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that a pre-RNA containing mutations in SE2 is deployed following the 3 nt 3605 to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="439">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that pre-mRNAs of all these genes is deployed following few or no exon-spatched to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="440">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that pre-mRNAs of all these genes is deployed following little or no exon spacer to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacer</arg>
                </example>
                <example src="PERMUTATE" no="441">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that pre-mRNAs of all these genes is deployed following little or no exon to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="442">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that pre-mRNAs of all these genes is predominantly deployed following few or no exon-spatch to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="443">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that pre-mRNAs of all these genes is predominantly deployed following few or no splash exon to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="444">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that substrate C2Gloi2 is predominantly deployed following the exon escapement pathway to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="445">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes can be divided predominantly by following few or no splash exon to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="446">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes can be inclined following little or no exon spacing to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="447">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes has the ability to be divided following few or no exon-spatch to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="448">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes has the ability to be divided following little or no exon spacer to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacer</arg>
                </example>
                <example src="PERMUTATE" no="449">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes has the ability to be divided following little or no exon spacing to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="450">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes has the ability to be divided following little or no exon to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="451">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes has the ability to be divided following little or no exon-spatched to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="452">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes has the ability to be divided predominantly following few or no spatter exon to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="PERMUTATE" no="453">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes has the ability to be divided predominantly following little or no exon-spatch to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="454">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes is able to be deployed following little or no exon spacing to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="455">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes may have been deployed predominantly following few or no splash exon to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="456">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes may have been deployed predominantly following little or no exon spacer to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacer</arg>
                </example>
                <example src="PERMUTATE" no="457">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes may have been deployed predominantly following little or no exon spatter to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="458">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes may have been imputed following few or no exon-spatch to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="459">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes will be deployed predominantly following few or no exon-spatched to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="460">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes will be deployed predominantly following little or no exon splash to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon splash</arg>
                </example>
                <example src="PERMUTATE" no="461">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, substrate C2Gloi2 can be divided predominantly by following exon escapement pathway to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="462">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, substrate C2Gloi2 can be inclined following the exon escapement pathway to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="463">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, substrate C2Gloi2 is able to be deployed following exon escapement pathway to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="464">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, substrate C2Gloi2 may have been deployed predominantly following exon escapement pathway to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="465">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, substrate C2Gloi2 may have been deployed predominantly following the exon escapement pathway to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="466">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, substrate C2Gloi2 will be deployed predominantly following exon escapement pathway to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="467">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, the Supt4h gene can be inclined following five exons coded by chromosome 11 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="468">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, the Supt4h gene is able to be deployed following five exons coded by chromosome 11 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="469">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, Pre-RNAs of all these genes is predominantly sectioned following little or no exon-pulping to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 to line 1.</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="470">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, Pre-mRNA of all these genes is predominantly sectioned following small or no exon escapement to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 to line 1.</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="471">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, Pre-mRNAs of all these genes is predominantly sectioned following few or no exon-spatch to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 to line 1.</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="472">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, Pre-mRNAs of all these genes will be inclined after little or no exon-skipping to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="473">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, a pre-RNA containing mutations in SE2 is divided following the 3 nt 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="474">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, a pre-RNA containing mutations in SE2 is predominantly sectioned following the 3 nt 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="475">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, a pre-mRNA mutation containing EE2 will be inclined after nt 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="476">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, gen Supt4h is predominantly sectioned following five exons to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="477">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, gen Supt4h will be inclined after five exons to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="478">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, pre-mRNAs of all these genes is divided following little or no exon spacer to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacer</arg>
                </example>
                <example src="PERMUTATE" no="479">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, pre-mRNAs of all these genes is divided following little or no exon spacing to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="480">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, pre-mRNAs of all these genes is divided following little or no exon splash to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon splash</arg>
                </example>
                <example src="PERMUTATE" no="481">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, pre-mRNAs of all these genes is divided following little or no exon to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="482">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, pre-mRNAs of all these genes is predominantly sectioned following few or no exon-spatched to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 to line 1.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="483">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, pre-mRNAs of all these genes is predominantly sectioned following few or no splash exon to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="484">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, pre-mRNAs of all these genes is predominantly sectioned following little or no exon spacer to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacer</arg>
                </example>
                <example src="PERMUTATE" no="485">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, pre-mRNAs of all these genes is predominantly sectioned following little or no exon-spatched to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="486">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, pre-mRNAs of all these genes is predominantly sectioned following little or no exon-spatched to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 to line 1.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="487">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, pre-mRNAs of all these genes will be inclined after little or no exon spacing to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="488">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, pre-mRNAs of all these genes will be inclined after little or no exon spatter to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="489">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, C2Gloi2 substrate can be spliced following exon escaping route to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="490">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, C2Gloi2 substrate can be spliced predominantly by following exonon scaling route to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="491">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, C2Gloi2 substrate is spliced predominantly following exonon scaling route to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="492">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, C2Gloi2 substrate is spliced predominantly following via exon-skipping to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="493">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, C2Gloi2 substrate will be spliced after exon-skipping to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="494">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, C2Gloi2 substrate will be spliced after via exon-skipping to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="495">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, C2Gloi2 substrate will be spliced predominantly after exon escaping route to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="496">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, Pre-RNAs of all these genes is spliced predominantly following little or no exon-pulping to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="497">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, Pre-mRNA of all these genes can be spliced predominantly by following small or no exon escapement to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare line 3 with line 1).</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="498">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-RNA containing SE2 mutations can be spliced predominantly by following nt 3605 slice 3 site to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="PERMUTATE" no="499">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-RNA containing SE2 mutations will be spliced after nt 3605 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="500">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-RNA containing mutations in SE2 is able to be spliced following a 3605 3 coupling site to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="501">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-RNA containing mutations in SE2 is spliced following the 3 nt 3605 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="502">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that C2Gloi2 substrate is spliced after via exon-skipping at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="503">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that C2Gloi2 substrate is spliced predominantly after exonon escaping route at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="504">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that Pre-RNAs of all these genes is spliced predominantly after little or no exon-pulping at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="505">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that Supt4h gene is spliced predominantly after five exons coded by chromosome 11 at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="506">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that pre-mRNAs of all these genes is spliced after few or no exon-spatch at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="507">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that pre-mRNAs of all these genes is spliced after few or no spatter exon at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="PERMUTATE" no="508">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that pre-mRNAs of all these genes is spliced after little or no exon splash at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon splash</arg>
                </example>
                <example src="PERMUTATE" no="509">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that pre-mRNAs of all these genes is spliced after little or no exon-spatched at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="510">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that pre-mRNAs of all these genes is spliced predominantly after few or no spatter exon at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="PERMUTATE" no="511">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that pre-mRNAs of all these genes is spliced predominantly after little or no exon spacer at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacer</arg>
                </example>
                <example src="PERMUTATE" no="512">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that pre-mRNAs of all these genes is spliced predominantly after little or no exon-spatch at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="513">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that pre-mRNAs of all these genes is spliced predominantly after little or no exon-spatched at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="514">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that substrate C2Gloi2 is spliced after exon escapement pathway at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="515">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes can be spliced following few or no exon-spatch to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="516">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes can be spliced following little or no exon spacing to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="517">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes can be spliced following little or no exon-spatched to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="518">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes can be spliced predominantly by following few or no spatter exon to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="PERMUTATE" no="519">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes can be spliced predominantly by following few or no splash exon to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare line 3 with line 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="520">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes can be spliced predominantly by following little or no exon spacing to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="521">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes can be spliced predominantly by following little or no exon splash to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon splash</arg>
                </example>
                <example src="PERMUTATE" no="522">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes can be spliced predominantly by following little or no exon-spatch to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare line 3 with line 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="523">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes can be spliced predominantly by following little or no exon-spatched to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="524">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes is able to be spliced following few or no spatter exon to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="PERMUTATE" no="525">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes is able to be spliced following little or no exon-spatch to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="526">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes is spliced following little or no exon spatter to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="527">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes is spliced predominantly following little or no exon spacing to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="528">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes will be spliced after few or no exon-spatched to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="529">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes will be spliced after few or no splash exon to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="530">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, pre-mRNAs of all these genes will be spliced after little or no exon spacing to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="531">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, substrate C2Gloi2 is spliced predominantly following exon escapement pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="532">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the Supt4h gene can be spliced following five exons coded by chromosome 11 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="533">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the Supt4h gene is able to be spliced following five exons coded by chromosome 11 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="534">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, C2Gloi2 substrate has been predominantly spliced following exon escaping route to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="535">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, C2Gloi2 substrate has been predominantly spliced following exonon escaping pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="536">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, C2Gloi2 substrate has been spliced following exon escaping route to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="537">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, C2Gloi2 substrate has the abality to be spliced after exon escaping route at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="538">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, C2Gloi2 substrate is able to be spliced predominantly by following exonon escaping pathway to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares line 3 with line 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping pathway</arg>
                </example>
                <example src="PERMUTATE" no="539">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, C2Gloi2 substrate is able to be spliced predominantly by following via exon-skipping to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares line 3 with line 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">via exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="540">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, C2Gloi2 substrate may have been spliced predominantly by following exonon escaping route to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare line 3 with line 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon escaping route</arg>
                </example>
                <example src="PERMUTATE" no="541">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, C2Gloi2 substrate may have been spliced predominantly by following exonon scaling route to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare line 3 with line 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="542">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, Pre-RNAs of all these genes has been spliced following little or no exon-pulping to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="543">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, Pre-mRNA of all these genes has been predominantly spliced following small or no exon escapement to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">Pre-mRNA of all these genes</arg>
                    <arg n="1">small or no exon escapement</arg>
                </example>
                <example src="PERMUTATE" no="544">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, Pre-mRNAs of all these genes has been predominantly spliced following few or no exon-spatch to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="545">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, Pre-mRNAs of all these genes has been predominantly spliced following little or no exon-skipping to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="546">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, Pre-mRNAs of all these genes has the abality to be spliced predominantly after little or no exon-skipping at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="547">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, Supt4h gene has been spliced following five exons coded by chromosome 11 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="548">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, Supt4h gene may have been spliced predominantly by following five exons coded by chromosome 11 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare line 3 with line 1).</text>
                    <arg n="0">Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="549">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, a pre-RNA containing SE2 mutations has the abality to be spliced after nt 3605 slice 3 site at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="PERMUTATE" no="550">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, a pre-mRNA mutation containing EE2 has been spliced following nt 3605 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="551">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, gen Supt4h is able to be spliced predominantly by following five exons to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares line 3 with line 1).</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="552">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, pre-mRNAs of all these genes has been predominantly spliced following few or no splash exon to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="553">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, pre-mRNAs of all these genes has been predominantly spliced following little or no exon spatter to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="554">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, pre-mRNAs of all these genes has been predominantly spliced following little or no exon-spatched to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="555">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, pre-mRNAs of all these genes has the abality to be spliced after little or no exon spacer at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacer</arg>
                </example>
                <example src="PERMUTATE" no="556">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, pre-mRNAs of all these genes has the abality to be spliced predominantly after little or no exon at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="557">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, pre-mRNAs of all these genes has the abality to be spliced predominantly after little or no exon spacing at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="558">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, pre-mRNAs of all these genes has the abality to be spliced predominantly after little or no exon spatter at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="559">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, pre-mRNAs of all these genes is able to be spliced predominantly by following few or no exon-spatch to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares line 3 with line 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="560">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, pre-mRNAs of all these genes is able to be spliced predominantly by following little or no exon to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares line 3 with line 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="561">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, pre-mRNAs of all these genes is able to be spliced predominantly by following little or no exon-spatch to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares line 3 with line 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="562">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, pre-mRNAs of all these genes may have been spliced predominantly by following few or no exon-spatch to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare line 3 with line 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="563">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, the Supt4h gene has the abality to be spliced predominantly after five exons coded by chromosome 11 at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="564">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, the Supt4h gene is able to be spliced predominantly by following five exons coded by chromosome 11 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares line 3 with line 1).</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="565">
                    <text>When incubated in nuclear or transfected extracts in HeLa cells, C2Gloi2 substrate is able to be spliced predominantly following exonon scaling route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 with line 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="566">
                    <text>When incubated in nuclear or transfected extracts in HeLa cells, a pre-RNA containing mutations in SE2 is able to be spliced predominantly following the 3 nt 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 with line 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="567">
                    <text>When incubated in nuclear or transfected extracts in HeLa cells, gen Supt4h is able to be spliced predominantly following five exons to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 with line 1).</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="568">
                    <text>When incubated in nuclear or transfected extracts in HeLa cells, pre-mRNAs of all these genes is able to be spliced predominantly following little or no exon splash to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 with line 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon splash</arg>
                </example>
                <example src="PERMUTATE" no="569">
                    <text>When incubated in nuclear or transfected extracts in HeLa cells, pre-mRNAs of all these genes is able to be spliced predominantly following little or no exon-spatch to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 with line 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="570">
                    <text>When incubated into nuclear extracts or spliced into HeLa cells, the A0 substrate (C2Gloi2) is found to be deployed after exon 30 with intron at a level similar to that obtained with the C2 substrate (undisplayed data and Fig. 2).</text>
                    <arg n="1">exon 30 with intron</arg>
                </example>
                <example src="PERMUTATE" no="571">
                    <text>When incubated into nuclear extracts or spliced into HeLa cells, the A0 substrate (C2Gloi2) is found to be deployed after exon 30 with the intron, as suggested by our study at a level similar to that obtained with the C2 substrate (undisplayed data and Fig. 2).</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study</arg>
                </example>
                <example src="PERMUTATE" no="572">
                    <text>When incubated into nuclear extracts or spliced into HeLa cells, the A0 substrate (C2Gloi2) is found to be deployed after exon 30 with the intron, as suggested by our study, at a level similar to that obtained with the C2 substrate (undisplayed data and Fig. 2).</text>
                    <arg n="1">exon 30 with the intron, as suggested by our study,</arg>
                </example>
                <example src="PERMUTATE" no="573">
                    <text>When spliced in nuclear extracts or transfects in HeLa cells, a pre-RNA containing SE2 mutations may have been impaled by following nt 3605 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="574">
                    <text>When spliced in nuclear extracts or transfects in HeLa cells, pre-mRNAs of all these genes may have been impaled by following little or no exon spacer to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacer</arg>
                </example>
                <example src="PERMUTATE" no="575">
                    <text>When spliced in nuclear extracts or transfects in HeLa cells, pre-mRNAs of all these genes may have been impaled by following little or no exon spacing to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="576">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, C2Gloi2 substrate was predominantly deployed after exonon scaling route to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">C2Gloi2 substrate</arg>
                    <arg n="1">exonon scaling route</arg>
                </example>
                <example src="PERMUTATE" no="577">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, Pre-RNAs of all these genes was inclined following little or no exon-pulping to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">Pre-RNAs of all these genes</arg>
                    <arg n="1">little or no exon-pulping</arg>
                </example>
                <example src="PERMUTATE" no="578">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, Pre-mRNAs of all these genes was inclined following little or no exon-skipping to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-skipping</arg>
                </example>
                <example src="PERMUTATE" no="579">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, Pre-mRNAs of all these genes was predominantly deployed after few or no exon-spatch to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">Pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="580">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, a pre-RNA containing SE2 mutations was predominantly deployed after nt 3605 slice 3 site to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="PERMUTATE" no="581">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, pre-mRNAs of all these genes was inclined following few or no exon-spatch to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="582">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, pre-mRNAs of all these genes was inclined following few or no splash exon to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="583">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, pre-mRNAs of all these genes was predominantly deployed after little or no exon spatter to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="584">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, pre-mRNAs of all these genes was predominantly deployed after little or no exon splash to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon splash</arg>
                </example>
                <example src="PERMUTATE" no="585">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, substrate C2Gloi2 was predominantly deployed after the exon escapement pathway to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="586">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, the Supt4h gene was inclined following five exons coded by chromosome 11 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="587">
                    <text>a 654 nt exon is able to require additional exotic and/or intronic sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="588">
                    <text>a 654 nt exon requires extra-exonic and/or intrusive sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">a 654 nt exon</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="589">
                    <text>a caspasa-2 can be made and has been spliced into transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="590">
                    <text>a caspasa-2 could be done to be spliced into an alternative to transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="591">
                    <text>a caspasa-2 could be made to be alternatively spliced to transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="592">
                    <text>a caspasa-2 has the ability to be efficiently spliced transcent cells and nuclear extracts, and the ratio of casp-2S with the casp-2L mRNAs produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a caspasa-2</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="593">
                    <text>a caspasa-2 may have been demonstrated to be efficiently spliced transcent cells and nuclear extracts, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a caspasa-2</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="594">
                    <text>a caspasa-2 minigen construction has the ability to be efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S with the casp-2L mRNAs produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="595">
                    <text>a caspasa-2 minigen construction has the ability to be spliced into transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="596">
                    <text>a caspasa-2 minigen construction has the ability to be spliced into transcentric cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcentric cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="597">
                    <text>a caspasa-2 minigen construction is able to be efficiently spliced transcentric cells and nuclear extracts, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcentric cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="598">
                    <text>a caspasa-2 minigen construction is able to be efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="599">
                    <text>a caspasa-2 minigen construction is efficiently spliced transcent cells and nuclear extracts , and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="600">
                    <text>a caspasa-2 minigen construction is efficiently spliced transcentric cells and nuclear extracts , and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcentric cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="601">
                    <text>a caspasa-2 minigen construction is made to be alternatively spliced into transcentric cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcentric cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="602">
                    <text>a caspasa-2 minigen construction may have been demonstrated to be efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="603">
                    <text>a caspasa-2 minigen construction may have been done to be spliced into transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="604">
                    <text>a caspasa-2 minigen construction may have been efficiently spliced into transcentric cells and nuclear extracts, and the ratio of casp-2S to the produced casp-2L mRNA was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcentric cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="605">
                    <text>a caspasa-2 minigen construction may have been shown to be efficiently spliced transcentric cells and nuclear extracts , and the relationship between the produced casp-2 and casp-2L mRNAs is similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcentric cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="606">
                    <text>a caspasa-2 minigen construction was efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="607">
                    <text>a caspasa-2 minigen construction was made and it was spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="608">
                    <text>a caspasa-2 minigen construction was observed to be efficiently spliced transcent cells and nuclear extracts, and the ratio of casp-2S to the produced casp-2L mRNA was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="609">
                    <text>a caspasa-2 minigen construction will be done and is spliced into transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="610">
                    <text>a caspasa-2 minigen construction will be made to be alternatively spliced to transfected cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="611">
                    <text>a caspasa-2 minigen construction will be made to be spliced into transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="612">
                    <text>a caspasa-2 minigen construction would be made and could be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="613">
                    <text>a caspasa-2 will be done and is spliced into transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="614">
                    <text>a caspasa-2 will be made to be alternatively spliced to transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="615">
                    <text>a caspasa-2 will be made to be spliced into transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="616">
                    <text>a caspasa-2 would be made and could be spliced into transcent cells and nuclear extracts.</text>
                    <arg n="0">a caspasa-2</arg>
                    <arg n="3">transcent cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="617">
                    <text>a minigen caspasa-2 building could be done to be spliced into an alternative to transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="618">
                    <text>a minigen caspasa-2 building has the ability to be alternatively spliced in transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="619">
                    <text>a minigen caspasa-2 building has the ability to be efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="620">
                    <text>a minigen caspasa-2 building is constituted and can be spliced into transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="621">
                    <text>a minigen caspasa-2 building is efficiently spliced transient cells and nuclear extracts , and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="622">
                    <text>a minigen caspasa-2 building is observed to be efficiently spliced transfected cells and nuclear extracts , and the relationship between the produced casp-2S and casp-2L mRNAs is similar to that seen in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="623">
                    <text>a minigen caspasa-2 building may have been efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="624">
                    <text>a minigen caspasa-2 building may have been efficiently spliced transient cells and nuclear extracts, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="625">
                    <text>a minigen caspasa-2 building may have been spliced to be efficiently impaled transient cells and nuclear extracts, and the relationship between the CASp-2S and casp-2L mRNAs produced was similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="626">
                    <text>a minigen caspasa-2 building minigen construction would cause it to be spliced to transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="627">
                    <text>a minigen caspasa-2 building was observed to be efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S to the produced casp-2L mRNA was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="628">
                    <text>a minigen caspasa-2 building will be made to be spliced into transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="629">
                    <text>a minigen caspasa-2 building would be made and could be spliced into transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="630">
                    <text>a minigen caspasa-2 construction can be done to be spliced into an alternative to transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="631">
                    <text>a minigen caspasa-2 construction can be made to be alternatively spliced to transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="632">
                    <text>a minigen caspasa-2 construction can be made to be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="633">
                    <text>a minigen caspasa-2 construction can be made to be spliced into transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="634">
                    <text>a minigen caspasa-2 construction has the ability to be alternatively spliced in transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="635">
                    <text>a minigen caspasa-2 construction is able to be made and is spliced into transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="636">
                    <text>a minigen caspasa-2 construction may have been efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="637">
                    <text>a minigen caspasa-2 construction may have been shown to be efficiently spliced transfected cells and nuclear extracts , and the relationship between the produced casp-2 and casp-2L mRNAs is similar to the observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="638">
                    <text>a minigen caspasa-2 construction may have been shown to be efficiently spliced transient cells and nuclear extracts, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="639">
                    <text>a minigen caspasa-2 construction will be done to be spliced in an alternative with transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspasa-2 construction</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="640">
                    <text>a minigen caspase-2 building can be done to be alternately spliced into transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="641">
                    <text>a minigen caspase-2 building has been made to be spliced into transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="642">
                    <text>a minigen caspase-2 building has been spliced to be used alternatively in transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="643">
                    <text>a minigen caspase-2 building has the ability to be spliced into transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="644">
                    <text>a minigen caspase-2 building was made and it was spliced into transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="645">
                    <text>a minigen caspase-2 building will be done and is spliced into transient cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 building</arg>
                    <arg n="3">transient cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="646">
                    <text>a minigen caspase-2 construction can be efficiently spliced into transfected cells and nuclear extracts, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="647">
                    <text>a minigen caspase-2 construction can be made to be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="648">
                    <text>a minigen caspase-2 construction could be made to alternately spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="649">
                    <text>a minigen caspase-2 construction has also been spliced, which have been observed to be spalmated but contain no obvious open reading framework.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                </example>
                <example src="PERMUTATE" no="650">
                    <text>a minigen caspase-2 construction has the ability to be efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="651">
                    <text>a minigen caspase-2 construction is able to be efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="652">
                    <text>a minigen caspase-2 construction is able to be efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="653">
                    <text>a minigen caspase-2 construction is able to be made and is spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="654">
                    <text>a minigen caspase-2 construction may have been done to be spliced in an alternative with transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="655">
                    <text>a minigen caspase-2 construction will be done and is spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="656">
                    <text>a minigen caspase-2 construction will be made to be alternatively spliced to transfected cells and nuclear extracts.</text>
                    <arg n="0">a minigen caspase-2 construction</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="657">
                    <text>a pre-RNA containing SE2 mutations are able to be spliced with nt 3605 (ref. 16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machinery.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="658">
                    <text>a pre-RNA containing SE2 mutations can be spliced with nt 3605 (ref.16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="659">
                    <text>a pre-RNA containing SE2 mutations can be spliced with nt 3605 slice 3 site (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="PERMUTATE" no="660">
                    <text>a pre-RNA containing SE2 mutations can normally be spliced from nt 3605.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="661">
                    <text>a pre-RNA containing SE2 mutations can usually be divided from the nt 3605 spliced by chromosome 11.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="662">
                    <text>a pre-RNA containing SE2 mutations has been spliced to be generally cut from nt 3605 slice 3 site.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="PERMUTATE" no="663">
                    <text>a pre-RNA containing SE2 mutations is able to be normally spliced from nt 3605 slice 3 site.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="PERMUTATE" no="664">
                    <text>a pre-RNA containing SE2 mutations is observed as normally spliced from nt 3605.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="665">
                    <text>a pre-RNA containing SE2 mutations is observed to be deployed with nt 3605 (ref.16; also Fig. 1 C and data not presented), spliced that correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="666">
                    <text>a pre-RNA containing SE2 mutations is shown to be spliced with nt 3605 (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="667">
                    <text>a pre-RNA containing SE2 mutations that can be spliced with nt 3605 slice 3 site (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="PERMUTATE" no="668">
                    <text>a pre-RNA containing SE2 mutations that have been spliced with nt 3605 slice 3 site (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="PERMUTATE" no="669">
                    <text>a pre-RNA containing SE2 mutations that have the ability to be spliced with nt 3605 (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="670">
                    <text>a pre-RNA containing SE2 mutations was normally spliced from nt 3605 slice 3 site.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="PERMUTATE" no="671">
                    <text>a pre-RNA containing SE2 mutations was shown to be spliced with nt 3605 slice 3 site (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be treated by yeast genes expression machines.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605 slice 3 site</arg>
                </example>
                <example src="PERMUTATE" no="672">
                    <text>a pre-RNA containing SE2 mutations, however, will predominantly be spliced with nt 3605.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="673">
                    <text>a pre-RNA containing mutations in SE2 are observed splashed with a 3605 3 coupling site (ref.16; also Fig. 1 C and data not presented) spliced that correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="674">
                    <text>a pre-RNA containing mutations in SE2 can normally be spliced from nt splicetion site 3605 3.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt splicetion site 3605 3</arg>
                </example>
                <example src="PERMUTATE" no="675">
                    <text>a pre-RNA containing mutations in SE2 has been shown to be composed of A3 spliced (transfected cells and nuclear extracts).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                </example>
                <example src="PERMUTATE" no="676">
                    <text>a pre-RNA containing mutations in SE2 has the ability to be spliced with a 3605 3 coupling site (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="677">
                    <text>a pre-RNA containing mutations in SE2 is able to be normally spliced from a 3605 3 coupling site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="678">
                    <text>a pre-RNA containing mutations in SE2 spliced splashed with the 3 nt 3605 (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="679">
                    <text>a pre-RNA containing mutations in SE2 spread with a 3605 3 coupling site (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="680">
                    <text>a pre-RNA containing mutations in SE2 spread with nt splicetion site 3605 3 (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt splicetion site 3605 3</arg>
                </example>
                <example src="PERMUTATE" no="681">
                    <text>a pre-RNA containing mutations in SE2 that are able to be spliced with a 3605 3 coupling site (ref. 16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="682">
                    <text>a pre-RNA containing mutations in SE2 that can be spliced with the 3 nt 3605 (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="683">
                    <text>a pre-RNA containing mutations in SE2 that may have been defocused with the 3 nt 3605 (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="684">
                    <text>a pre-RNA containing mutations in SE2 that may have been spliced with a 3605 3 coupling site (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="685">
                    <text>a pre-RNA containing mutations in SE2 that were spliced with the 3 nt 3605 (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="686">
                    <text>a pre-RNA containing mutations in SE2 were observed to be spliced with nt splicetion site 3605 3 (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt splicetion site 3605 3</arg>
                </example>
                <example src="PERMUTATE" no="687">
                    <text>a pre-RNA containing mutations in SE2 which were deployed with nt splicetion site 3605 3 (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt splicetion site 3605 3</arg>
                </example>
                <example src="PERMUTATE" no="688">
                    <text>a pre-RNA containing mutations in SE2 will normally be spliced from nt splicetion site 3605 3.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt splicetion site 3605 3</arg>
                </example>
                <example src="PERMUTATE" no="689">
                    <text>a pre-RNA containing mutations in SE2 will usually be spliced from the 3 nt 3605.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="690">
                    <text>a pre-RNA containing mutations in SE2, however, is likely to be predominantly spliced with a 3605 3 coupling site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="691">
                    <text>a pre-RNA containing mutations in SE2, however, was predominantly divided with a 3605 3 coupling site spliced site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="692">
                    <text>a pre-RNA containing mutations in SE2, however, will predominantly be spliced with a 3605 3 coupling site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">a 3605 3 coupling site</arg>
                </example>
                <example src="PERMUTATE" no="693">
                    <text>a pre-mRNA mutation containing EE2 has been spliced to be generally cut from nt 3605.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="694">
                    <text>a pre-mRNA mutation containing EE2 have been spliced with nt 3605 (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="695">
                    <text>a pre-mRNA mutation containing EE2 were observed to be spliced with nt 3605 (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">nt 3605</arg>
                </example>
                <example src="PERMUTATE" no="696">
                    <text>an exon 654 nt are effectively spliced into the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="697">
                    <text>an exon 654 nt has been shown to require additional exonic and/or intrusive sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="698">
                    <text>an exon 654 nt has been shown to require additional exotic and/ or intrusive sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="699">
                    <text>an exon 654 nt have been spliced into the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="700">
                    <text>an exon 654 nt is able to require additional exotic and/or intronic sequences to be spliced into mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="701">
                    <text>an exon 654 nt is actually spliced into mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="702">
                    <text>an exon 654 nt is likely to require additional exotic and/or intrusive sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="703">
                    <text>an exon 654 nt may have required additional exotic and/ or intronic sequences to be spliced into the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="704">
                    <text>an exon 654 nt may have required additional exotic and/ or intrusive sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="705">
                    <text>an exon 654 nt required additional exotic and/or intron sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="706">
                    <text>an exon 654 nt was spliced into the mRNA.</text>
                    <arg n="1">an exon 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="707">
                    <text>an exon nt 654 are effectively spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="708">
                    <text>an exon nt 654 has been shown to require additional exonic and/or intrusive sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="709">
                    <text>an exon nt 654 has been shown to require additional exonic and/or intrusive sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="710">
                    <text>an exon nt 654 has been shown to require additional exotic and/ or intrusive sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="711">
                    <text>an exon nt 654 have the probability of requiring additional exonic and/or intrusive sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="712">
                    <text>an exon nt 654 is able to require additional exotic and/or intronic sequences to be spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="713">
                    <text>an exon nt 654 is likely to require additional exotic and/or intrusive sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="714">
                    <text>an exon nt 654 may have required additional exotic and/ or intrusive sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="715">
                    <text>an exon nt 654 required additional exotic and/or intron sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="716">
                    <text>an exon nt 654 requires additional exonic and/or intronic sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="717">
                    <text>an exon nt 654 requires additional exotic and/ or intronic sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="718">
                    <text>an exon nt 654 requires extra exonic and/or intrusive sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="719">
                    <text>an exon nt 654 was effectively spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="720">
                    <text>an exon nt 654 were effectively spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="721">
                    <text>an exon nt 654 were spliced into the mRNA.</text>
                    <arg n="1">an exon nt 654</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="722">
                    <text>an exon of 654 nt has been shown to require additional exotic and/ or intrusive sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="723">
                    <text>an exon of 654 nt have been effectively spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="724">
                    <text>an exon of 654 nt have required additional exonic and/or intronic sequences to be spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="725">
                    <text>an exon of 654 nt have the probability of requiring additional exonic and/or intrusive sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="726">
                    <text>an exon of 654 nt is able to require additional exotic and/or intron sequences to be spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="727">
                    <text>an exon of 654 nt may have required additional exotic and/ or intrusive sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="728">
                    <text>an exon of 654 nt required additional exotic and/or intron sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="729">
                    <text>an exon of 654 nt requires additional exotic and/or intronic sequences to be spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="730">
                    <text>an exon of 654 nt requires extra exonic and/or intrusive sequences to be effectively spliced into the mRNA.</text>
                    <arg n="1">an exon of 654 nt</arg>
                    <arg n="2">the mRNA</arg>
                </example>
                <example src="PERMUTATE" no="731">
                    <text>exon 654 nt have required additional exonic and/or intronic sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="732">
                    <text>exon 654 nt is able to require additional exotic and/or intronic sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="733">
                    <text>exon 654 nt may have required additional exotic and/or intron sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="734">
                    <text>exon 654 nt may require additional exotic and/ or intrusive sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="735">
                    <text>exon 654 nt may require additional exotic and/or intrusive sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="736">
                    <text>exon 654 nt may require extra exonic and/or intrusive sequences to be spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="737">
                    <text>exon 654 nt may require extra-exotic and/ or intrusive sequences to be spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="738">
                    <text>exon 654 nt requires extra exonic and/or intrusive sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="739">
                    <text>exon 654 nt was effectively spliced into mRNA.</text>
                    <arg n="1">exon 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="740">
                    <text>exon of 654 nt are effectively spliced into mRNA.</text>
                    <arg n="1">exon of 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="741">
                    <text>exon of 654 nt has been shown to require additional exotic and/ or intrusive sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">exon of 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="742">
                    <text>exon of 654 nt may have required additional exotic and/ or intrusive sequences to be effectively spliced into mRNA.</text>
                    <arg n="1">exon of 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="743">
                    <text>exon of 654 nt was effectively spliced into mRNA.</text>
                    <arg n="1">exon of 654 nt</arg>
                    <arg n="2">mRNA</arg>
                </example>
                <example src="PERMUTATE" no="744">
                    <text>exons outside this range of size is likely to require additional exotic and/or intrusive sequences to be spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="745">
                    <text>exons outside this range of size may require additional exotic and/ or intrusive sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="746">
                    <text>exons outside this range of size may require extra exonic and/or intrusive sequences to be spliced into mature RNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="747">
                    <text>exons outside this range of size requires extra-exonic and/or intrusive sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="748">
                    <text>exons outside this range of size was effectively spliced into mature RNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="749">
                    <text>exons outside this range of size was effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="750">
                    <text>exons outside this range of size were spliced into mature RNA.</text>
                    <arg n="1">exons outside this range of size</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="751">
                    <text>exons outside this size range have been effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="752">
                    <text>exons outside this size range is able to require additional exotic and/or intron sequences to be spliced into mature RNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="753">
                    <text>exons outside this size range is actually spliced into mature RNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="754">
                    <text>exons outside this size range is likely to require additional exotic and/or intrusive sequences to be effectively spliced into mature RNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="755">
                    <text>exons outside this size range may have required additional exotic and/or intron sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="756">
                    <text>exons outside this size range may require additional exotic and/or intrusive sequences to be effectively spliced into mature mRNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature mRNA</arg>
                </example>
                <example src="PERMUTATE" no="757">
                    <text>exons outside this size range requires additional exonic and/or intronic sequences to be effectively spliced into mature RNA.</text>
                    <arg n="1">exons outside this size range</arg>
                    <arg n="2">mature RNA</arg>
                </example>
                <example src="PERMUTATE" no="758">
                    <text>four transcriptive units has been shown to be composed of A3 spliced (transfected cells and nuclear extracts).</text>
                    <arg n="0">four transcriptive units</arg>
                </example>
                <example src="PERMUTATE" no="759">
                    <text>gen Supt4h are able to be spliced with five exons (ref. 16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machinery.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="760">
                    <text>gen Supt4h are observed splashed with five exons (ref.16; also Fig. 1 C and data not presented) spliced that correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="761">
                    <text>gen Supt4h has the ability to be spliced with five exons (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="762">
                    <text>gen Supt4h have the ability to be spliced with five exons (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="763">
                    <text>gen Supt4h that can be spliced with five exons (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="764">
                    <text>gen Supt4h that can be spliced with five exons (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="765">
                    <text>gen Supt4h that have the ability to be spliced with five exons (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="766">
                    <text>gen Supt4h was shown to be spliced with five exons (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be treated by yeast genes expression machines.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="767">
                    <text>gen Supt4h was spliced with five exons (ref. 16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by yeast genes expression machines.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="768">
                    <text>gen Supt4h which have the ability to be spliced with five exons (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="769">
                    <text>gen Supt4h which were spliced with five exons (ref.16; also Fig. 1 C and data not presented) suggests that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="770">
                    <text>gen Supt4h which will be spliced with five exons (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="771">
                    <text>gen Supt4h, however, has the ability to be alternately divided with five exons spliced site.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="772">
                    <text>gen Supt4h, however, was predominantly divided with five exons spliced site.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="PERMUTATE" no="773">
                    <text>minigenous caspase-2 can be made to be alternatively spliced to transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="774">
                    <text>minigenous caspase-2 can be made to be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="775">
                    <text>minigenous caspase-2 has been spliced to be used alternatively in transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="776">
                    <text>minigenous caspase-2 has the ability to be efficiently spliced transfected cells and nuclear extracts, and the relationship between the CASp-2S and casp-2L mRNAs produced was similar to that observed in vivo (Fig.1 C, lane 1).</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="777">
                    <text>minigenous caspase-2 is efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="778">
                    <text>minigenous caspase-2 may have been demonstrated to be efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="779">
                    <text>minigenous caspase-2 may have been done to be spliced in an alternative with transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="780">
                    <text>minigenous caspase-2 may have been made to be alternatively spliced to transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="781">
                    <text>minigenous caspase-2 may have been shown to be efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="782">
                    <text>minigenous caspase-2 was efficiently spliced transfected cells and nuclear extracts, and the ratio of casp-2S to the produced casp-2L mRNA was similar to the observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="783">
                    <text>minigenous caspase-2 will be made to be spliced into transfected cells and nuclear extracts.</text>
                    <arg n="0">minigenous caspase-2</arg>
                    <arg n="3">transfected cells and nuclear extracts</arg>
                </example>
                <example src="PERMUTATE" no="784">
                    <text>pre-mRNAs of all these genes are able to be spliced with few or no spatter exon (ref. 16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="PERMUTATE" no="785">
                    <text>pre-mRNAs of all these genes are able to be spliced with little or no exon splash (ref. 16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon splash</arg>
                </example>
                <example src="PERMUTATE" no="786">
                    <text>pre-mRNAs of all these genes are observed splashed with few or no exon-spatched (ref.16; also Fig. 1 C and data not presented) spliced that correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="787">
                    <text>pre-mRNAs of all these genes are observed splashed with few or no splash exon (ref.16; also Fig. 1 C and data not presented) spliced that correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="788">
                    <text>pre-mRNAs of all these genes are observed to be spliced with few or no exon-spatched (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="789">
                    <text>pre-mRNAs of all these genes are observed to be spliced with little or no exon spacer (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacer</arg>
                </example>
                <example src="PERMUTATE" no="790">
                    <text>pre-mRNAs of all these genes are observed to be spliced with little or no exon spatter (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="791">
                    <text>pre-mRNAs of all these genes are shown to be spliced with little or no exon spacing (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="792">
                    <text>pre-mRNAs of all these genes are shown to be spliced with little or no exon-spatched (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="793">
                    <text>pre-mRNAs of all these genes can be spliced with few or no exon-spatched (ref.16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="794">
                    <text>pre-mRNAs of all these genes can be spliced with few or no splash exon (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="795">
                    <text>pre-mRNAs of all these genes can be spliced with little or no exon (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="796">
                    <text>pre-mRNAs of all these genes can be spliced with little or no exon-spatch (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="797">
                    <text>pre-mRNAs of all these genes can normally be spliced from few or no spatter exon.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="PERMUTATE" no="798">
                    <text>pre-mRNAs of all these genes has the ability to be normally spliced from few or no exon-spatch.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="799">
                    <text>pre-mRNAs of all these genes has the ability to be normally spliced from few or no spatter exon.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="PERMUTATE" no="800">
                    <text>pre-mRNAs of all these genes have been spliced with few or no exon-spatched (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="801">
                    <text>pre-mRNAs of all these genes have been spliced with few or no splash exon (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="802">
                    <text>pre-mRNAs of all these genes have been spliced with little or no exon-spatched (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="803">
                    <text>pre-mRNAs of all these genes is able to be normally spliced from few or no splash exon.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="804">
                    <text>pre-mRNAs of all these genes is able to be spliced normally from few or no exon-spatched.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="805">
                    <text>pre-mRNAs of all these genes is able to be spliced normally from little or no exon-spatched.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="806">
                    <text>pre-mRNAs of all these genes is able to be spliced normally from little or no exon.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="807">
                    <text>pre-mRNAs of all these genes is able to normally be spliced from little or no exon spacing.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="808">
                    <text>pre-mRNAs of all these genes is able to normally be spliced from little or no exon.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="809">
                    <text>pre-mRNAs of all these genes is observed as normally spliced from few or no splash exon.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="810">
                    <text>pre-mRNAs of all these genes is observed as normally spliced from little or no exon spatter.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="811">
                    <text>pre-mRNAs of all these genes is observed as normally spliced from little or no exon-spatched.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="812">
                    <text>pre-mRNAs of all these genes is observed to be deployed with few or no exon-spatch (ref.16; also Fig. 1 C and data not presented), spliced that correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="813">
                    <text>pre-mRNAs of all these genes is observed to be normally spliced from little or no exon spatter.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="814">
                    <text>pre-mRNAs of all these genes is observed to be normally spliced from little or no exon splash.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon splash</arg>
                </example>
                <example src="PERMUTATE" no="815">
                    <text>pre-mRNAs of all these genes is shown to be spliced with little or no exon spatter (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="816">
                    <text>pre-mRNAs of all these genes may have been normally spliced from little or no exon splash.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon splash</arg>
                </example>
                <example src="PERMUTATE" no="817">
                    <text>pre-mRNAs of all these genes may have been spliced normally from few or no spatter exon.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="PERMUTATE" no="818">
                    <text>pre-mRNAs of all these genes may have been spliced normally from few or no splash exon.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="819">
                    <text>pre-mRNAs of all these genes may have been spliced normally from little or no exon spacing.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="820">
                    <text>pre-mRNAs of all these genes may have been spliced normally from little or no exon-spatch.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="821">
                    <text>pre-mRNAs of all these genes may have been spliced with few or no exon-spatch (ref.16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="822">
                    <text>pre-mRNAs of all these genes spliced splashed with little or no exon spacing (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacing</arg>
                </example>
                <example src="PERMUTATE" no="823">
                    <text>pre-mRNAs of all these genes spread with little or no exon (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="824">
                    <text>pre-mRNAs of all these genes that are able to be spliced with little or no exon spatter (ref. 16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="825">
                    <text>pre-mRNAs of all these genes that can be spliced with few or no spatter exon (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="PERMUTATE" no="826">
                    <text>pre-mRNAs of all these genes that can be spliced with little or no exon (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="827">
                    <text>pre-mRNAs of all these genes that can be spliced with little or no exon-spatch (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="828">
                    <text>pre-mRNAs of all these genes that may have been spliced with few or no splash exon (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="829">
                    <text>pre-mRNAs of all these genes that may have been spliced with little or no exon spatter (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="830">
                    <text>pre-mRNAs of all these genes was generally spliced from little or no exon spatter.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="831">
                    <text>pre-mRNAs of all these genes was normally spliced from little or no exon splash.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon splash</arg>
                </example>
                <example src="PERMUTATE" no="832">
                    <text>pre-mRNAs of all these genes was normally spliced from little or no exon-spatch.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="833">
                    <text>pre-mRNAs of all these genes was shown to be spliced with little or no exon spacer (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be treated by yeast genes expression machines.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spacer</arg>
                </example>
                <example src="PERMUTATE" no="834">
                    <text>pre-mRNAs of all these genes was shown to be spliced with little or no exon spatter (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be treated by yeast genes expression machines.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="835">
                    <text>pre-mRNAs of all these genes was spliced with few or no exon-spatch (ref. 16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by yeast genes expression machines.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="836">
                    <text>pre-mRNAs of all these genes was spliced with few or no exon-spatched (ref. 16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by yeast genes expression machines.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="837">
                    <text>pre-mRNAs of all these genes was spliced with little or no exon (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="838">
                    <text>pre-mRNAs of all these genes were spliced with little or no exon splash (ref.16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon splash</arg>
                </example>
                <example src="PERMUTATE" no="839">
                    <text>pre-mRNAs of all these genes which have the ability to be spliced with few or no exon-spatched (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="840">
                    <text>pre-mRNAs of all these genes which have the ability to be spliced with little or no exon spatter (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="841">
                    <text>pre-mRNAs of all these genes which have the ability to be spliced with little or no exon splash (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon splash</arg>
                </example>
                <example src="PERMUTATE" no="842">
                    <text>pre-mRNAs of all these genes which were deployed with few or no splash exon (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="843">
                    <text>pre-mRNAs of all these genes which were deployed with little or no exon (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="844">
                    <text>pre-mRNAs of all these genes which were spliced with little or no exon splash (ref.16; also Fig. 1 C and data not presented) suggests that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon splash</arg>
                </example>
                <example src="PERMUTATE" no="845">
                    <text>pre-mRNAs of all these genes which will be spliced with few or no exon-spatch (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatch</arg>
                </example>
                <example src="PERMUTATE" no="846">
                    <text>pre-mRNAs of all these genes which will be spliced with few or no spatter exon (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no spatter exon</arg>
                </example>
                <example src="PERMUTATE" no="847">
                    <text>pre-mRNAs of all these genes which will be spliced with little or no exon spatter (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="848">
                    <text>pre-mRNAs of all these genes will normally be spliced from few or no splash exon.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no splash exon</arg>
                </example>
                <example src="PERMUTATE" no="849">
                    <text>pre-mRNAs of all these genes, however, has the ability to be alternately divided with few or no exon-spatched spliced site.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">few or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="850">
                    <text>pre-mRNAs of all these genes, however, has the ability to be alternately divided with little or no exon spatter spliced site.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon spatter</arg>
                </example>
                <example src="PERMUTATE" no="851">
                    <text>pre-mRNAs of all these genes, however, may have been alternately spliced predominantly with little or no exon slice 3 site.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="852">
                    <text>pre-mRNAs of all these genes, however, was predominantly divided with little or no exon spliced site.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon</arg>
                </example>
                <example src="PERMUTATE" no="853">
                    <text>pre-mRNAs of all these genes, however, was predominantly divided with little or no exon-spatched spliced site.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="854">
                    <text>pre-mRNAs of all these genes, however, will predominantly be spliced with little or no exon-spatched.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                    <arg n="1">little or no exon-spatched</arg>
                </example>
                <example src="PERMUTATE" no="855">
                    <text>substrate C2Gloi2 can be spliced with the exon escapement pathway (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="856">
                    <text>substrate C2Gloi2 can usually be divided from the exon escapement pathway spliced by chromosome 11.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="857">
                    <text>substrate C2Gloi2 has the ability to be spliced with the exon escapement pathway (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="858">
                    <text>substrate C2Gloi2 is observed as normally spliced from the exon escapement pathway.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="859">
                    <text>substrate C2Gloi2 is shown to be spliced with the exon escapement pathway (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="860">
                    <text>substrate C2Gloi2 that can be spliced with exon escapement pathway (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="861">
                    <text>substrate C2Gloi2 that may have been spliced with exon escapement pathway (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="862">
                    <text>substrate C2Gloi2 which have the ability to be spliced with the exon escapement pathway (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="863">
                    <text>substrate C2Gloi2 which were spliced with the exon escapement pathway (ref.16; also Fig. 1 C and data not presented) suggests that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="864">
                    <text>substrate C2Gloi2 will usually be spliced from the exon escapement pathway.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">the exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="865">
                    <text>substrate C2Gloi2, however, will predominantly be spliced with exon escapement pathway.</text>
                    <arg n="0">substrate C2Gloi2</arg>
                    <arg n="1">exon escapement pathway</arg>
                </example>
                <example src="PERMUTATE" no="866">
                    <text>the Supt4h gene are able to be spliced with five exons coded by chromosome 11 (ref. 16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machinery.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="867">
                    <text>the Supt4h gene have the ability to be spliced with five exons coded by chromosome 11 (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="868">
                    <text>the Supt4h gene is able to normally be spliced from five exons coded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="869">
                    <text>the Supt4h gene is observed to be normally spliced from five exons coded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="870">
                    <text>the Supt4h gene that can be spliced with five exons coded by chromosome 11 (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="871">
                    <text>the Supt4h gene were spliced with five exons coded by chromosome 11 (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="872">
                    <text>the Supt4h gene which were deployed with five exons coded by chromosome 11 (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="873">
                    <text>the Supt4h gene, however, is likely to be predominantly spliced with five exons coded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons coded by chromosome 11</arg>
                </example>
                <example src="PERMUTATE" no="874">
                    <text>the casp-2 minigen (C2) can be made to be spliced into in vitro.</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="875">
                    <text>the casp-2 minigen (C2) could be done to be spliced into an alternative to in vitro.</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="876">
                    <text>the casp-2 minigen (C2) is able to be efficiently spliced in vitro, and the ratio of casp-2S with the casp-2L mRNA produced was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="877">
                    <text>the casp-2 minigen (C2) is observed to be spliced into in vitro.</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="878">
                    <text>the casp-2 minigen (C2) may have been done to be spliced into in vitro.</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="879">
                    <text>the casp-2 minigen (C2) may have been made to be spliced into in vitro.</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="880">
                    <text>the casp-2 minigen (C2) was made and it was spliced into in vitro.</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="881">
                    <text>the casp-2 minigen (C2) was observed to be efficiently spliced in vitro, and the ratio of casp-2S to the produced casp-2L mRNA was similar to that observed in vivo (Fig. 1 C, lane 1).</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="882">
                    <text>the casp-2 minigen (C2) would be made and could be spliced into in vitro.</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="PERMUTATE" no="883">
                    <text>the casp-2 minigen (C2) would cause it to be alternatively spliced into in vitro.</text>
                    <arg n="0">the casp-2 minigen (C2)</arg>
                    <arg n="3">in vitro</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>Consequently, five exons encoded by chromosome 11 may have been spliced.</text>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>Consequently, five exons encoded by chromosome 11 spliced spalted.</text>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>Consequently, five exons encoded by chromosome 11 was spliced.</text>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>However, a caspasa-2 minigen construction can be spliced predominantly by A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>However, a caspasa-2 minigen construction will predominantly be spliced into A1 (the site of slice nt 3605 3.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>However, a mNN pre-RNA containing SE2 mutations was predominantly spliced into A1 (the site of slice nt 3605 3.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>However, a mNN pre-RNA containing SE2 mutations was spliced predominantly into A1 (the site of section nt 3605 3.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>However, a pre-RNA containing SE2 mutations is alternately spliced predominantly using the 3 nt spliced site 3605.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>However, a pre-RNA containing mutations in SE2 is alternately spliced predominantly using the splice nt 3605 site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>However, a pre-RNA containing mutations in SE2 is likely to be spliced more frequently with nt 3605 3 splice site slice site is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2 mutations).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>However, a pre-mRNA that contains mutations in SE2 will be spliced predominantly into A1 (the site of section nt 3605 3.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>However, a pre-mRNA that contains mutations in SE2 will predominantly be spliced into A1 (the site of slice nt 3605 3.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>However, gen Supt4h was spliced predominantly by A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">gen Supt4h</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>However, it is likely that a pre-mRNA that contains mutations in SE2 will divide more frequently with the spliced site the nt 3605 3 splice site is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2).</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>However, it is likely that gen Supt4h will divide more frequently with the spliced site five exons encoded by chromosome 11 is a growth factor that can be used in patients with A1 (a pre-RNA containing SE2).</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>However, it is likely that the Supt4h gene is predominantly spliced with five exons slice 3 site.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>However, pre-mRNAs of all these genes was spliced predominantly by A1 (a spraying site of NT 3605 3.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>However, pre-mRNAs of all these genes will predominantly be spliced into A1 (the site of slice nt 3605 3.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>It has been shown that a mNN pre-RNA that contains mutations in SE2 can be spliced with the splice nt 3605 3 site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>It has been shown that a pre-RNA containing mutations in SE2 can be spliced with the splice site 3 nt 3605 (ref.16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>It has been shown that a pre-mRNA mutation containing EE2 can be spliced with the site of 3, 505 and 3 splices (ref.16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>It has been shown that gen Supt4h can be spliced with five exons encoded by chromosome 11 (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>The a mNN pre-RNA containing SE2 mutations that have been pinned with the splice site nt 3605 3 (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by the yeasts gene expression machinery.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice site nt 3605 3</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>The a mNN pre-RNA that contains mutations in SE2 splashed with the splice nt 3605 3 site (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by yeast gene expression machinery.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>The a pre-RNA containing SE2 mutations may have been spliced with the 3 nt spliced site 3605 (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>The a pre-RNA containing SE2 mutations splashed with the 3 nt spliced site 3605 (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>The a pre-RNA containing mutations in SE2 that have been pinned with the splice site 3 nt 3605 (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by the yeasts gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>The a pre-mRNA mutation containing EE2 that have been pinned with the site of 3, 505 and 3 splices (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by the yeasts gene expression machinery.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>The a pre-mRNA that contains mutations in SE2 may have been spliced with the nt 3605 3 splice site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeasts gene expression machinery.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>The structure of different cDNA clones indicates that a caspasa-2 minigen construction has been shown to be differentially spliced, and the alternative use of exons can regulate functional USF protein levels.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>The structure of different cDNA clones indicates that a caspasa-2 minigen construction has the ability to be spliced, and the alternative use of exons can regulate the functional levels of USF protein.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>The structure of different cDNA clones indicates that a caspasa-2 minigen construction is observed as being spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>The structure of different cDNA clones indicates that a mNN pre-RNA containing SE2 mutations is able to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>The structure of different cDNA clones indicates that a mNN pre-RNA containing SE2 mutations was differentially spliced, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>The structure of different cDNA clones indicates that a mNN pre-RNA that contains mutations in SE2 can be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>The structure of different cDNA clones indicates that a mNN pre-RNA that contains mutations in SE2 has been spliced differently, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>The structure of different cDNA clones indicates that a mNN pre-RNA that contains mutations in SE2 has the ability to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>The structure of different cDNA clones indicates that a mNN pre-RNA that contains mutations in SE2 will be spliced, and the alternative use of exons may regulate the functional USF protein levels.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>The structure of different cDNA clones indicates that a pre-mRNA containing mutations in SE2 is capable of being spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>The structure of different cDNA clones indicates that a pre-mRNA containing mutations in SE2 is spliced to be spalmate, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>The structure of different cDNA clones indicates that a pre-mRNA containing mutations in SE2 was differentially spliced, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>The structure of different cDNA clones indicates that a pre-mRNA that contains mutations in SE2 is able to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>The structure of different cDNA clones indicates that a pre-mRNA that contains mutations in SE2 is capable of being spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>The structure of different cDNA clones indicates that gen Supt4h has been demonstrated to be spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">gen Supt4h</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>The structure of different cDNA clones indicates that gen Supt4h has the ability to be spliced, and the alternative use of exons can regulate the functional levels of USF protein.</text>
                    <arg n="0">gen Supt4h</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>The structure of different cDNA clones indicates that gen Supt4h is capable of being spliced, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">gen Supt4h</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>The structure of different cDNA clones indicates that gen Supt4h may have been spliced, and the alternative use of exon may regulate the functional USF protein levels.</text>
                    <arg n="0">gen Supt4h</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>The structure of different cDNA clones indicates that gen Supt4h may have been spliced, and the alternative use of exons may regulate the functional USF protein levels.</text>
                    <arg n="0">gen Supt4h</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>The structure of different cDNA clones indicates that pre-mRNAs of all these genes can be spliced differently, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>The structure of different cDNA clones indicates that pre-mRNAs of all these genes will be spliced differently, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>The structure of different cDNA clones indicates that the Supt4h gene may have been spliced, and the alternative use of exons may regulate the functional USF protein levels.</text>
                    <arg n="0">the Supt4h gene</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>The structure of different cDNA clones indicates that the Supt4h gene will be spliced differently, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">the Supt4h gene</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>The structure of different cDNA clones spliced that a caspasa-2 minigen construction has the ability to be palatined, and the alternative use of exons can regulate the protein levels of functional USF.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>The structure of different cDNA clones spliced that a mNN pre-RNA containing SE2 mutations may be differential coupling, and the alternative use of exons may regulate the functional USF protein levels.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>The structure of different cDNA clones spliced that a mNN pre-RNA that contains mutations in SE2 has the ability to be palatined, and the alternative use of exons can regulate the protein levels of functional USF.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>The structure of different cDNA clones spliced that gen Supt4h has been pulsed, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">gen Supt4h</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>The structure of different cDNA clones spliced that gen Supt4h is able to spray, and the alternative use of exons can regulate the functional USF protein levels.</text>
                    <arg n="0">gen Supt4h</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>The structure of different cDNA clones spliced that the Supt4h gene has been blurred, and the alternative use of exon can regulate the functional USF protein levels.</text>
                    <arg n="0">the Supt4h gene</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>The structure of the different cDNA DNA clones indicates that a mNN pre-RNA containing SE2 mutations is spliced to be deployed, and the alternative use of the exon can regulate functional levels of USF proteins.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>The structure of the different cDNA DNA clones indicates that a mNN pre-RNA that contains mutations in SE2 is spliced to be deployed, and the alternative use of the exon can regulate functional levels of USF proteins.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>The the Supt4h gene splashed with five exons encoded by chromosome 11 (ref.16; also Fig.1 C and undisplayed data) suggests that the correct inclusion of the exon can be spliced by yeast gene expression machinery.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>We also identified a caspasa-2 minigen construction that were observed as being differentially spliced, but do not contain an open reading table.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>We also identified a mNN pre-RNA containing SE2 mutations that could have been differentially spliced but did not contain any obvious open reading framework.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>We also identified a pre-mRNA containing mutations in SE2 that are observed as being of spliced tissue, but do not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>We also identified a pre-mRNA containing mutations in SE2 that were spliced differently, but do not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>We also identified a pre-mRNA that contains mutations in SE2 that could have been differentially spliced, but did not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>We also identified a pre-mRNA that contains mutations in SE2 that may have been spliced differently, but that do not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>We also identified the Supt4h gene that could have been differentially spliced, but did not contain any obvious open reading frame.</text>
                    <arg n="0">the Supt4h gene</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>We also identified the Supt4h gene that were differentially spliced but did not contain any obvious open reading framework.</text>
                    <arg n="0">the Supt4h gene</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>We also identify a caspasa-2 minigen construction being able to be spliced, but without an obvious open reading.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>We also identify a caspasa-2 minigen construction that are able to be differentially spliced, but do not have an obvious open reading structure.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>We also identify a caspasa-2 minigen construction that are spliced as being unfolded, but they do not have an open reading table.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>We also identify a caspasa-2 minigen construction that can be spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>We also identify a mNN pre-RNA containing SE2 mutations that can be spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>We also identify a mNN pre-RNA containing SE2 mutations that may have been spread, but does not spliced any obvious open reading frame.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>We also identify a mNN pre-RNA that contains mutations in SE2 that can be spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>We also identify a pre-mRNA containing mutations in SE2 that may have been spread, but does not spliced any obvious open reading frame.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>We also identify a pre-mRNA that contains mutations in SE2 that can be spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>We also identify a pre-mRNA that contains mutations in SE2 that will be spliced differently, but do not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>We also identify a pre-mRNA that contains mutations in SE2 that will be spliced, but do not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>We also identify gen Supt4h that are able to be spliced, but do not have an obvious open reading structure.</text>
                    <arg n="0">gen Supt4h</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>We also identify pre-mRNAs of all these genes being able to be spliced, but without a clear open reading structure.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>We also identify the Supt4h gene that are able to be spliced, but do not have an obvious open reading structure.</text>
                    <arg n="0">the Supt4h gene</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>We also identify the Supt4h gene that may have been spread, but does not spliced any obvious open reading frame.</text>
                    <arg n="0">the Supt4h gene</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>We also identify the Supt4h gene that will be spliced differently, but do not contain any obvious open reading frame.</text>
                    <arg n="0">the Supt4h gene</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>We also spliced a mNN pre-RNA containing SE2 mutations that proved to be differentially from each other, but does not contain any obvious open reading frame.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>We also spliced a mNN pre-RNA containing SE2 mutations that were different from each other, but do not contain any open obvious reading frame.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>We also spliced a mNN pre-RNA containing SE2 mutations that were found to be blurred, but did not contain an obvious open reading structure.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>We also spliced a mNN pre-RNA containing SE2 mutations that were spalmated but did not contain any obvious open reading framework.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>We also spliced a mNN pre-RNA that contains mutations in SE2 that proved to be differentially from each other, but does not contain any obvious open reading frame.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>We also spliced a pre-mRNA containing mutations in SE2 that proved to be differentially from each other, but does not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>We also spliced a pre-mRNA that contains mutations in SE2 that could have been spread, but did not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>We also spliced a pre-mRNA that contains mutations in SE2 that were found to be blurred, but without a clear open reading structure.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>We also spliced a pre-mRNA that contains mutations in SE2 that were spread, but did not contain any obvious open reading frame.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>We have also identified a caspasa-2 minigen construction that have been spliced to be differentially interwoven but do not contain any obvious open reading framework.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>We have also identified a mNN pre-RNA containing SE2 mutations that can be spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>We have also identified a mNN pre-RNA containing SE2 mutations that has been spliced to be differentially interwoven but does not contain any obvious open reading framework.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>We have also identified a mNN pre-RNA that contains mutations in SE2 that may have been differentially spliced, but that do not contain any obvious open reading framework.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>We have also identified a pre-mRNA containing mutations in SE2 spliced but without an obvious open reading framework.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>We have also identified a pre-mRNA containing mutations in SE2 that will be differentially spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>We have also identified a pre-mRNA that contains mutations in SE2 that have been observed to be differentially spliced but contain no obvious open reading framework.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>We have also identified gen Supt4h that have been spliced to be differentially interwoven but do not contain any obvious open reading framework.</text>
                    <arg n="0">gen Supt4h</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>We have also identified pre-mRNAs of all these genes that can be differentially spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>We have also identified pre-mRNAs of all these genes that can be spliced but do not contain any obvious open reading framework.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>We have also identified pre-mRNAs of all these genes which has been spliced to be spalmated but does not contain any obvious open reading framework.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>We have also spliced a mNN pre-RNA containing SE2 mutations that could have been spalmated but did not contain any obvious open reading framework.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>We have also spliced a pre-mRNA containing mutations in SE2 that will be cut but do not contain any obvious open reading framework.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>We have also spliced a pre-mRNA that contains mutations in SE2 that may have been spalted but does not contain any obvious open reading framework.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>We have also spliced pre-mRNAs of all these genes that will be cut but do not contain any obvious open reading framework.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>We have also spliced that the Supt4h gene can be spalated but does not contain any obvious open reading framework.</text>
                    <arg n="0">the Supt4h gene</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a mNN pre-RNA containing SE2 mutations is able to be deployed following the splice site nt 3605 3 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice site nt 3605 3</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a mNN pre-RNA containing SE2 mutations will be deployed predominantly following the splice site nt 3605 3 to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice site nt 3605 3</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a mNN pre-RNA that contains mutations in SE2 may have been deployed predominantly following the splice nt 3605 3 site to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing SE2 mutations can be divided predominantly by following the 3 nt spliced site 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing SE2 mutations may have been imputed following the splice 3 nt 3605 site to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing mutations in SE2 can be divided predominantly by following the 3 nt splice site 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing mutations in SE2 can be inclined following the 3 nt splice site 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing mutations in SE2 can be inclined following the splice site 3 nt 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing mutations in SE2 is able to be deployed following the splice nt 3605 3 site to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing mutations in SE2 may have been imputed following the 3 nt splice site 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing mutations in SE2 will be deployed predominantly following the 3 nt splice site 3605 to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-RNA containing mutations in SE2 will be deployed predominantly following the splice site 3 nt 3605 to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-mRNA containing mutations in SE2 has the ability to be divided predominantly following the nt 3605 3 splice site to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, a pre-mRNA mutation containing EE2 has the ability to be divided predominantly following the site of 3, 505 and 3 splices to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it has been shown that a pre-mRNA that contains mutations in SE2 is predominantly unfolded after the nt 3605 3 splice site at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that a pre-RNA containing mutations in SE2 is deployed following nt 3605 3 splice site to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that a pre-RNA containing mutations in SE2 is predominantly deployed following nt 3605 3 splice site to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that a pre-mRNA containing mutations in SE2 is deployed following the nt 3605 3 splice site to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that a pre-mRNA that contains mutations in SE2 is deployed following the nt 3605 3 splice site to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, it is observed that gen Supt4h is deployed following five exons encoded by chromosome 11 to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, pre-mRNAs of all these genes can be divided predominantly following the A1 level (exonon scaling route) to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, the Supt4h gene has the ability to be divided following five exons to a level similar to that obtained with C2 substrate (data not shown and Fig. 2 E, compare lane 3 with lane 1).</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>When incubated in nuclear extracts or spliced in HeLa cells, the Supt4h gene will be deployed predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with C2 substrate (data not shown and Fig. 2).</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, a pre-RNA containing SE2 mutations is divided following the splice 3 nt 3605 site to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, a pre-RNA containing mutations in SE2 is divided following the 3 nt splice site 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, a pre-RNA containing mutations in SE2 is predominantly sectioned following nt 3605 3 splice site to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, a pre-RNA containing mutations in SE2 is predominantly sectioned following the 3 nt splice site 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, a pre-RNA containing mutations in SE2 is predominantly sectioned following the splice nt 3605 site to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, a pre-RNA containing mutations in SE2 will be inclined after the splice nt 3605 3 site to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, a pre-mRNA that contains mutations in SE2 is predominantly sectioned following the nt 3605 3 splice site to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, the Supt4h gene is divided following five exons to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, the Supt4h gene is predominantly sectioned following five exons encoded by chromosome 11 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 to line 1.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>When incubated in nuclear extracts or spliced into HeLa cells, the Supt4h gene is predominantly sectioned following five exons to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 to line 1.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a mNN pre-RNA containing SE2 mutations can be spliced following the splice site nt 3605 3 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice site nt 3605 3</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a mNN pre-RNA containing SE2 mutations is able to be spliced following the splice site nt 3605 3 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice site nt 3605 3</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-RNA containing SE2 mutations can be spliced predominantly by following the 3 nt spliced site 3605 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare line 3 with line 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-RNA containing SE2 mutations is spliced following the splice 3 nt 3605 site to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-RNA containing SE2 mutations is spliced predominantly following the 3 nt spliced site 3605 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-RNA containing SE2 mutations will be spliced predominantly after the 3 nt spliced site 3605 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-RNA containing mutations in SE2 can be spliced following nt 3605 3 splice site to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-RNA containing mutations in SE2 is spliced predominantly following the splice nt 3605 3 site to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-mRNA containing mutations in SE2 is spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-mRNA mutation containing EE2 can be spliced predominantly by following the site of 3, 505 and 3 splices to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, a pre-mRNA mutation containing EE2 will be spliced after the site of 3, 505 and 3 splices to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, gen Supt4h can be spliced following five exons encoded by chromosome 11 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, gen Supt4h will be spliced after five exons encoded by chromosome 11 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that a mNN pre-RNA that contains mutations in SE2 is spliced after the splice nt 3605 3 site at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that a pre-RNA containing mutations in SE2 is spliced after the 3 nt splice site 3605 at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that a pre-RNA containing mutations in SE2 is spliced after the splice nt 3605 3 site at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that a pre-RNA containing mutations in SE2 is spliced after the splice nt 3605 3 site at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that a pre-mRNA mutation containing EE2 is spliced after the site of 3, 505 and 3 splices at a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that a pre-mRNA that contains mutations in SE2 is spliced after the nt 3605 3 splice site at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, it has been shown that gen Supt4h is spliced predominantly after five exons encoded by chromosome 11 at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the Supt4h gene can be spliced predominantly by following five exons to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare line 3 with line 1).</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>When incubated in nuclear extracts or transfected in HeLa cells, the Supt4h gene can be spliced predominantly by following five exons to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, a mNN pre-RNA containing SE2 mutations has the abality to be spliced predominantly after the splice site nt 3605 3 at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice site nt 3605 3</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, a pre-RNA containing SE2 mutations is able to be spliced predominantly by following the 3 nt spliced site 3605 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares line 3 with line 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, a pre-RNA containing mutations in SE2 is able to be spliced predominantly by following nt 3605 3 splice site to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares line 3 with line 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, a pre-RNA containing mutations in SE2 is able to be spliced predominantly by following the 3 nt splice site 3605 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares line 3 with line 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, a pre-RNA containing mutations in SE2 may have been spliced predominantly by following the splice nt 3605 3 site to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare line 3 with line 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, a pre-RNA containing mutations in SE2 may have been spliced predominantly by following the splice site 3 nt 3605 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compare line 3 with line 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, a pre-mRNA containing mutations in SE2 has been predominantly spliced following the nt 3605 3 splice site to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, a pre-mRNA containing mutations in SE2 has the abality to be spliced after the nt 3605 3 splice site at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, a pre-mRNA mutation containing EE2 has been spliced following the site of 3, 505 and 3 splices to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, a pre-mRNA that contains mutations in SE2 has been predominantly spliced following the nt 3605 3 splice site to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>When incubated in nuclear extracts or transfects in HeLa cells, the Supt4h gene has the abality to be spliced after five exons at a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compares lane 3 to lane 1).</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>When incubated in nuclear or transfected extracts in HeLa cells, the Supt4h gene is able to be spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 and compares line 3 with line 1).</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>When spliced in nuclear extracts or transfects in HeLa cells, a mNN pre-RNA that contains mutations in SE2 may have been impaled by following the splice nt 3605 3 site to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>When spliced in nuclear extracts or transfects in HeLa cells, a pre-RNA containing SE2 mutations may have been impaled by following the 3 nt spliced site 3605 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>When spliced in nuclear extracts or transfects in HeLa cells, a pre-RNA containing SE2 mutations may have been impaled by following the splice 3 nt 3605 site to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>When spliced in nuclear extracts or transfects in HeLa cells, a pre-RNA containing mutations in SE2 may have been impaled by following the splice nt 3605 3 site to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>When spliced in nuclear extracts or transfects in HeLa cells, a pre-RNA containing mutations in SE2 may have been impaled by following the splice site 3 nt 3605 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>When spliced in nuclear extracts or transfects in HeLa cells, gen Supt4h may have been impaled by following five exons encoded by chromosome 11 to a level similar to that obtained with substrate C2 (undisplayed data and Fig.2 E, compared lane 3 to lane 1).</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, a pre-RNA containing mutations in SE2 was inclined following the 3 nt splice site 3605 to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, a pre-RNA containing mutations in SE2 was predominantly deployed after nt 3605 3 splice site to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>When spliced in nuclear or transfected extracts in HeLa cells, a pre-mRNA containing mutations in SE2 was inclined following the nt 3605 3 splice site to a level similar to that obtained with C2 substrate (unexposed data and Fig. 2 E, compared to lane 3 to lane 1).</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>a caspasa-2 minigen construction has been shown to be composed of A3 spliced (transfected cells and nuclear extracts).</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>a caspasa-2 minigen construction was also spliced, which was observed to be spalmated, but does not contain an obvious open reading frame.</text>
                    <arg n="0">a caspasa-2 minigen construction</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>a mNN pre-RNA containing SE2 mutations can be spliced with the splice site nt 3605 3 (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice site nt 3605 3</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>a mNN pre-RNA containing SE2 mutations has been spliced to be generally cut from the splice site nt 3605 3.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice site nt 3605 3</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>a mNN pre-RNA containing SE2 mutations is observed to be deployed with the splice site nt 3605 3 (ref.16; also Fig. 1 C and data not presented), spliced that correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice site nt 3605 3</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>a mNN pre-RNA containing SE2 mutations may have been normally spliced from the splice site nt 3605 3.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice site nt 3605 3</arg>
                </example>
                <example src="REPLACE" no="193">
                    <text>a mNN pre-RNA containing SE2 mutations that have been spliced with the splice site nt 3605 3 (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice site nt 3605 3</arg>
                </example>
                <example src="REPLACE" no="194">
                    <text>a mNN pre-RNA containing SE2 mutations was normally spliced from the splice site nt 3605 3.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice site nt 3605 3</arg>
                </example>
                <example src="REPLACE" no="195">
                    <text>a mNN pre-RNA containing SE2 mutations was spliced with the splice site nt 3605 3 (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">a mNN pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice site nt 3605 3</arg>
                </example>
                <example src="REPLACE" no="196">
                    <text>a mNN pre-RNA that contains mutations in SE2 are observed to be spliced with the splice nt 3605 3 site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="197">
                    <text>a mNN pre-RNA that contains mutations in SE2 can be spliced with the splice nt 3605 3 site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="198">
                    <text>a mNN pre-RNA that contains mutations in SE2 have been shown to be spliced with the splice nt 3605 3 site (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="199">
                    <text>a mNN pre-RNA that contains mutations in SE2 have been spliced with the splice nt 3605 3 site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="200">
                    <text>a mNN pre-RNA that contains mutations in SE2 that have been spliced with the splice nt 3605 3 site (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="201">
                    <text>a mNN pre-RNA that contains mutations in SE2 was generally spliced from the splice nt 3605 3 site.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="202">
                    <text>a mNN pre-RNA that contains mutations in SE2 was normally spliced from the splice nt 3605 3 site.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="203">
                    <text>a mNN pre-RNA that contains mutations in SE2 was spliced with the splice nt 3605 3 site (ref. 16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by yeast genes expression machines.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="204">
                    <text>a mNN pre-RNA that contains mutations in SE2 which were deployed with the splice nt 3605 3 site (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a mNN pre-RNA that contains mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="205">
                    <text>a pre-RNA containing SE2 mutations are shown to be spliced with the splice 3 nt 3605 site (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="206">
                    <text>a pre-RNA containing SE2 mutations can be spliced with the splice 3 nt 3605 site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="207">
                    <text>a pre-RNA containing SE2 mutations can normally be spliced from the 3 nt spliced site 3605.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="208">
                    <text>a pre-RNA containing SE2 mutations has the ability to be normally spliced from the splice 3 nt 3605 site.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="209">
                    <text>a pre-RNA containing SE2 mutations is able to be normally spliced from the 3 nt spliced site 3605.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="210">
                    <text>a pre-RNA containing SE2 mutations may have been normally spliced from the splice 3 nt 3605 site.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="211">
                    <text>a pre-RNA containing SE2 mutations that are able to be spliced with the 3 nt spliced site 3605 (ref. 16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="212">
                    <text>a pre-RNA containing SE2 mutations that can be spliced with the splice 3 nt 3605 site (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="213">
                    <text>a pre-RNA containing SE2 mutations that can be spliced with the splice 3 nt 3605 site (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="214">
                    <text>a pre-RNA containing SE2 mutations that will be spliced with the 3 nt spliced site 3605 (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="215">
                    <text>a pre-RNA containing SE2 mutations that will be spliced with the splice 3 nt 3605 site (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="216">
                    <text>a pre-RNA containing SE2 mutations was normally spliced from the 3 nt spliced site 3605.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="217">
                    <text>a pre-RNA containing SE2 mutations were observed to be spliced with the splice 3 nt 3605 site (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="218">
                    <text>a pre-RNA containing SE2 mutations were spliced with the splice 3 nt 3605 site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="219">
                    <text>a pre-RNA containing SE2 mutations will usually be spliced from the 3 nt spliced site 3605.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="220">
                    <text>a pre-RNA containing SE2 mutations, however, has the ability to be alternately divided with the 3 nt spliced site 3605 spliced site.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="221">
                    <text>a pre-RNA containing SE2 mutations, however, may have been alternately spliced predominantly with the 3 nt spliced site 3605 slice 3 site.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the 3 nt spliced site 3605</arg>
                </example>
                <example src="REPLACE" no="222">
                    <text>a pre-RNA containing SE2 mutations, however, will predominantly be spliced with the splice 3 nt 3605 site.</text>
                    <arg n="0">a pre-RNA containing SE2 mutations</arg>
                    <arg n="1">the splice 3 nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="223">
                    <text>a pre-RNA containing mutations in SE2 are observed splashed with the splice site 3 nt 3605 (ref.16; also Fig. 1 C and data not presented) spliced that correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="224">
                    <text>a pre-RNA containing mutations in SE2 are observed to be spliced with the splice nt 3605 site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="225">
                    <text>a pre-RNA containing mutations in SE2 are shown to be spliced with the splice nt 3605 3 site (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="226">
                    <text>a pre-RNA containing mutations in SE2 can be spliced with the 3 nt splice site 3605 (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="227">
                    <text>a pre-RNA containing mutations in SE2 can be spliced with the splice nt 3605 site (ref.16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="228">
                    <text>a pre-RNA containing mutations in SE2 can be spliced with the splice site 3 nt 3605 (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="229">
                    <text>a pre-RNA containing mutations in SE2 can normally be spliced from the splice site 3 nt 3605.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="230">
                    <text>a pre-RNA containing mutations in SE2 has been spliced to be generally cut from the splice site 3 nt 3605.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="231">
                    <text>a pre-RNA containing mutations in SE2 has the ability to be spliced with the 3 nt splice site 3605 (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="232">
                    <text>a pre-RNA containing mutations in SE2 have been spliced with the splice nt 3605 3 site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="233">
                    <text>a pre-RNA containing mutations in SE2 is able to be spliced normally from the 3 nt splice site 3605.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="234">
                    <text>a pre-RNA containing mutations in SE2 is able to normally be spliced from the splice site 3 nt 3605.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="235">
                    <text>a pre-RNA containing mutations in SE2 is observed to be deployed with the splice site 3 nt 3605 (ref.16; also Fig. 1 C and data not presented), spliced that correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="236">
                    <text>a pre-RNA containing mutations in SE2 may have been normally spliced from the splice nt 3605 site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="237">
                    <text>a pre-RNA containing mutations in SE2 may have been spliced normally from the 3 nt splice site 3605.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="238">
                    <text>a pre-RNA containing mutations in SE2 spread with the 3 nt splice site 3605 (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="239">
                    <text>a pre-RNA containing mutations in SE2 spread with the splice nt 3605 site (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="240">
                    <text>a pre-RNA containing mutations in SE2 that can be spliced with the splice nt 3605 site (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="241">
                    <text>a pre-RNA containing mutations in SE2 that have been spliced with nt 3605 3 splice site (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="242">
                    <text>a pre-RNA containing mutations in SE2 that have the ability to be spliced with the 3 nt splice site 3605 (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="243">
                    <text>a pre-RNA containing mutations in SE2 that may have been defocused with the splice site 3 nt 3605 (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="244">
                    <text>a pre-RNA containing mutations in SE2 that were spliced with the splice site 3 nt 3605 (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="245">
                    <text>a pre-RNA containing mutations in SE2 that will be spliced with the 3 nt splice site 3605 (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="246">
                    <text>a pre-RNA containing mutations in SE2 was generally spliced from nt 3605 3 splice site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="247">
                    <text>a pre-RNA containing mutations in SE2 was generally spliced from the 3 nt splice site 3605.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="248">
                    <text>a pre-RNA containing mutations in SE2 was normally spliced from the 3 nt splice site 3605.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="249">
                    <text>a pre-RNA containing mutations in SE2 was normally spliced from the splice nt 3605 site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="250">
                    <text>a pre-RNA containing mutations in SE2 was spliced with the 3 nt splice site 3605 (ref. 16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by yeast genes expression machines.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="251">
                    <text>a pre-RNA containing mutations in SE2 was spliced with the splice nt 3605 3 site (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="252">
                    <text>a pre-RNA containing mutations in SE2 was spliced with the splice nt 3605 site (ref.16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="253">
                    <text>a pre-RNA containing mutations in SE2 were observed to be spliced with the splice nt 3605 3 site (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="254">
                    <text>a pre-RNA containing mutations in SE2 were observed to be spliced with the splice nt 3605 site (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="255">
                    <text>a pre-RNA containing mutations in SE2 were spliced with the splice nt 3605 3 site (ref.16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="256">
                    <text>a pre-RNA containing mutations in SE2 were spliced with the splice nt 3605 3 site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="257">
                    <text>a pre-RNA containing mutations in SE2 were spliced with the splice nt 3605 site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="258">
                    <text>a pre-RNA containing mutations in SE2 were spliced with the splice site 3 nt 3605 (ref.16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice site 3 nt 3605</arg>
                </example>
                <example src="REPLACE" no="259">
                    <text>a pre-RNA containing mutations in SE2 which have the ability to be spliced with the 3 nt splice site 3605 (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="260">
                    <text>a pre-RNA containing mutations in SE2 which were spliced with the splice nt 3605 3 site (ref.16; also Fig. 1 C and data not presented) suggests that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 3 site</arg>
                </example>
                <example src="REPLACE" no="261">
                    <text>a pre-RNA containing mutations in SE2 which were spliced with the splice nt 3605 site (ref.16; also Fig. 1 C and data not presented) suggests that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the splice nt 3605 site</arg>
                </example>
                <example src="REPLACE" no="262">
                    <text>a pre-RNA containing mutations in SE2 which will be spliced with the 3 nt splice site 3605 (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by the yeast genes expression machine.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="263">
                    <text>a pre-RNA containing mutations in SE2, however, has the ability to be alternately divided with the 3 nt splice site 3605 spliced site.</text>
                    <arg n="0">a pre-RNA containing mutations in SE2</arg>
                    <arg n="1">the 3 nt splice site 3605</arg>
                </example>
                <example src="REPLACE" no="264">
                    <text>a pre-mRNA containing mutations in SE2 are able to be spliced with the nt 3605 3 splice site (ref. 16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machinery.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="265">
                    <text>a pre-mRNA containing mutations in SE2 are observed to be spliced with the nt 3605 3 splice site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="266">
                    <text>a pre-mRNA containing mutations in SE2 that may have been defocused with the nt 3605 3 splice site (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="267">
                    <text>a pre-mRNA containing mutations in SE2 that will be spliced with the nt 3605 3 splice site (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="268">
                    <text>a pre-mRNA containing mutations in SE2 which have the ability to be spliced with the nt 3605 3 splice site (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-mRNA containing mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="269">
                    <text>a pre-mRNA mutation containing EE2 is observed to be deployed with the site of 3, 505 and 3 splices (ref.16; also Fig. 1 C and data not presented), spliced that correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="270">
                    <text>a pre-mRNA mutation containing EE2 is shown to be spliced with the site of 3, 505 and 3 splices (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="271">
                    <text>a pre-mRNA mutation containing EE2 may have been normally spliced from the site of 3, 505 and 3 splices.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="272">
                    <text>a pre-mRNA mutation containing EE2 that are able to be spliced with the site of 3, 505 and 3 splices (ref. 16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="273">
                    <text>a pre-mRNA mutation containing EE2 that have the ability to be spliced with the site of 3, 505 and 3 splices (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="274">
                    <text>a pre-mRNA mutation containing EE2 that may have been defocused with the site of 3, 505 and 3 splices (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="275">
                    <text>a pre-mRNA mutation containing EE2 were spliced with the site of 3, 505 and 3 splices (ref.16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="276">
                    <text>a pre-mRNA mutation containing EE2 which were deployed with the site of 3, 505 and 3 splices (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-mRNA mutation containing EE2</arg>
                    <arg n="1">the site of 3, 505 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="277">
                    <text>a pre-mRNA that contains mutations in SE2 is observed as normally spliced from the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="278">
                    <text>a pre-mRNA that contains mutations in SE2 is observed to be deployed with the nt 3605 3 splice site (ref.16; also Fig. 1 C and data not presented), spliced that correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="279">
                    <text>a pre-mRNA that contains mutations in SE2 that can be spliced with the nt 3605 3 splice site (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="280">
                    <text>a pre-mRNA that contains mutations in SE2 that will be spliced with the nt 3605 3 splice site (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="281">
                    <text>a pre-mRNA that contains mutations in SE2 were spliced with the nt 3605 3 splice site (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="282">
                    <text>a pre-mRNA that contains mutations in SE2, however, will predominantly be spliced with the nt 3605 3 splice site.</text>
                    <arg n="0">a pre-mRNA that contains mutations in SE2</arg>
                    <arg n="1">the nt 3605 3 splice site</arg>
                </example>
                <example src="REPLACE" no="283">
                    <text>gen Supt4h is observed to be deployed with five exons encoded by chromosome 11 (ref.16; also Fig. 1 C and data not presented), spliced that correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="284">
                    <text>gen Supt4h may have been spliced normally from five exons encoded by chromosome 11.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="285">
                    <text>gen Supt4h was generally spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="286">
                    <text>gen Supt4h were observed to be spliced with five exons encoded by chromosome 11 (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="287">
                    <text>gen Supt4h will normally be spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="288">
                    <text>gen Supt4h will usually be spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="289">
                    <text>gen Supt4h, however, may have been alternately spliced predominantly with five exons encoded by chromosome 11 slice 3 site.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="290">
                    <text>gen Supt4h, however, was predominantly divided with five exons encoded by chromosome 11 spliced site.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="291">
                    <text>gen Supt4h, however, will predominantly be spliced with five exons encoded by chromosome 11.</text>
                    <arg n="0">gen Supt4h</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="292">
                    <text>pre-mRNAs of all these genes has also been spliced, which have been observed to be spalmated but contain no obvious open reading framework.</text>
                    <arg n="0">pre-mRNAs of all these genes</arg>
                </example>
                <example src="REPLACE" no="293">
                    <text>the Supt4h gene are observed to be spliced with five exons encoded by chromosome 11 (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="294">
                    <text>the Supt4h gene are shown to be spliced with five exons (ref.16; also Fig.1 C and undisplayed data) suggest that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="295">
                    <text>the Supt4h gene can be spliced with five exons (ref.16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="296">
                    <text>the Supt4h gene can be spliced with five exons encoded by chromosome 11 (ref.16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="297">
                    <text>the Supt4h gene can be spliced with five exons encoded by chromosome 11 (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by yeast gene expression machinery.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="298">
                    <text>the Supt4h gene can normally be spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="299">
                    <text>the Supt4h gene can usually be divided from the five exons encoded by chromosome 11 spliced by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="300">
                    <text>the Supt4h gene has the ability to be normally spliced from five exons.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="301">
                    <text>the Supt4h gene is observed to be normally spliced from five exons encoded by chromosome 11.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="302">
                    <text>the Supt4h gene is shown to be spliced with five exons (ref.16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be managed by yeast genes expression machine.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="303">
                    <text>the Supt4h gene may have been spliced with five exons encoded by chromosome 11 (ref.16; also Fig. 1 C and data not presented), suggesting that the correct inclusion of exon can be managed by the yeast gene expression machine.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons encoded by chromosome 11</arg>
                </example>
                <example src="REPLACE" no="304">
                    <text>the Supt4h gene spread with five exons (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="305">
                    <text>the Supt4h gene that are able to be spliced with five exons (ref. 16; also Fig. 1 C and data not presented) suggest that the correct inclusion of exon can be controlled by the yeast genes expression machine.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="306">
                    <text>the Supt4h gene was shown to be spliced with five exons (ref. 16; also Fig. 1 C and data not presented) suggesting that the correct inclusion of exon can be treated by yeast genes expression machines.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="307">
                    <text>the Supt4h gene was spliced with five exons (ref. 16; also Fig. 1 C and data not exposed), suggesting that the correct inclusion of exon can be managed by yeast genes expression machines.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="308">
                    <text>the Supt4h gene were spliced with five exons (ref.16; also Fig.1 C and undisplayed data), suggesting that the correct inclusion of the exon can be handled by the yeast gene expression machinery.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="309">
                    <text>the Supt4h gene which were deployed with five exons (ref.16; also Fig. 1 C and data not presented) spliced that the correct inclusion of exon can be managed by a yeast gene expression machine.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
                <example src="REPLACE" no="310">
                    <text>the Supt4h gene, however, will predominantly be spliced with five exons.</text>
                    <arg n="0">the Supt4h gene</arg>
                    <arg n="1">five exons</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
